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Editorial 
Lauren Sham (Meds 2014) 
T hey say that medical school is the time in which you learn all the "zebras" - the we ird, wacky and wonderfu l diseases that pro-fessors briefl y mention as an aside in lecture, with the hope that 
one day you ' II spot the illusive black and white stripes in the crowd. 
They also say that you never forget every time you see a zebra. This 
seems to ring true in thi s Emergency and Criti cal Care issue, in which 
two of our articles reference the same case of sudden death of a young 
girl , but through di fferent lenses. One is through the eyes of our Zebra 
Files editors, who carefu lly analyzed the anatomica l basis for the sudden 
death. The other is through the eyes of Dr. Shiva Kaldindi, a pedi atric 
emergency physician refl ecting on patients that have affected him in hi s 
practice, during an interview with our Profil es editors. 
However, what's common is common, especially in the emergency 
room. Our editors have taken the "common" and put their own spin onto 
it, revealing the story behind many issues in Emergency and Critical 
Care. Roman Shapiro, Kim Fielding and Elaine Tang describe the medi-
cal trainee response to stressful situations, something that our second 
year students may want to familiarize themselves with before heading 
off into clerkship. Melissa MacPherson and Laura Callan discuss novel 
technological advances in communication, imaging and documentation 
in emergency care that may come into practice by the time we become 
physicians. Our Clinical Procedures editors further explore one of these 
technologies, Focused Assessment with Sonography for Trauma (FAST) 
and its role in abdominal trauma. Niran Argintaru and Jonathan Fair-
bairn outline the clinical, ethical and legal implications of Form I use, 
which gives physicians the abili ty to hold a patient without consent in a 
hospital. Our Interdi sciplinary Editors discuss the importance of inter-
professional collaboration, particularly in an acute care setting. Jason 
Chan and Justine Denomme vividly describe how medicine was dra-
matically changed during the course of the French Revolution, produc-
ing the fa ther of modem Emergency Medicine, Dominique Jean Lar-
rey. Stephanie Gottheil and Charlotte Hunter present the importance of 
breastfeeding in a unique li ght with its own set of challenges - for babies 
in the NICU. Our Diagnostic Review team review the vast array of bio-
markers for myocardial infarction , their pros, cons, and new techniques 
to come. 
In this issue we have al so expanded the scope of our feature articles to 
include a broader array of topics, instead of being confined to the issue 's 
theme. This has prov ided an increased capability to showcase students ' 
work and opinions in a variety of fi elds. ln this issue, Yin Hui discusses 
the new oral anticoagulants that have come to market, some of which 
have promising features; but she cautions us to not forego Warfarin just 
yet. Paul Kudlow and Daniel James describe a case of a schizophrenic 
patient who presented with a silent acute abdomen, an atypical presenta-
tion which can lead to dangerous misdiagnoses in the emergency room. 
Brennan Ballantyne and Josh Rosenblat provide us with an introduction 
EDITORIAL 
to Contrast-Enhanced Echocardiography, pointing out appl ications in 
assessing myocardial fl ow, imaging the peripheral vasculature, and even 
ultrasound-mediated gene and drug deli very with microbubbles. Yoan 
Kagoma gives an account of the use of transarterial chemoemboliza-
tion in hepatocellular carcinoma, in particular through the words of a 
patient 's experience, a unique view that we do not hear often enough. 
Finall y, Jean-Marc Beausoleil , a former paramedic, provides us with a 
primer on EMS operations, with the ai m of increas ing our awareness of 
the "pre-hospital setting" which most of us are unfa mili ar with . 
We hope that our Emergency and Criti cal Care issue provides you 
with a look at Emergency and Criti cal Care beyond the setting of the 
everyday ER. Keep an eye out for those "zebras"- you might just en-
counter them. 
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FEATURE ARTICLE 
A primer on EMS operations for physicians and 
medical trainees 
Jean-Marc Beausoleil, Primary Care Paramedic (Meds 2015) 
Faculty Reviewer: Dr. Michael Lewell , MD, FRCPC (Division of Emergency Medicine) 
There are two major theatres of emergency healthcare: the hospi-tal , with which physicians and trainees are familiar, and the pre-hospital setting. As a result, many healthcare workers know little 
about how the EMS system works, which can lead to confusion and 
delays when interactions do occur. This ' primer ' attempts to increase 
awareness of how Emergency Medical Services (EMS) are delivered 
and structured in the province of Ontario. 
OVERSIGHT AND DELEGATED ACTS 
Paramedics in Ontario are not currently part of the Regulated Health 
Professions Act (RHPA), and lack their own regulatory college (this is 
currently being examined, [I]). The Ministry of Health and Long Term 
Care (MOHLTC) still holds responsibility for regulating the paramedic 
profession. However, providing EMS has been the responsibi lity of up-
per-tier municipalities since 2000.2 
The ability to perform therapies that are considered controlled acts 
under the RHPA (e.g. administering a substance by injection or inha-
lation) are delegated to paramedics by physicians (Medical Directors) 
through the seven MOHLTC Regional Base Hospital Programs in On-
tario (see [3] for more information on delegation.) 
Together, the seven Regional Medical Directors form the Medical 
Advisory Committee that proposes new or revised medical directives. 
Final approval is dependent on provincial and EMS service management 
representatives, examining logistics and costs of implementation. The 
Medical Directives are based on the best available evidence, consider-
ing the limited diagnostic tools and resources available in an ambu lance. 
Treatment follows the specific conditions (e.g. for cardiac i chemia), 
contraindications, dosing and scheduling laid out in the medical direc-
tive for administration of the indicated drugs. However, a paramedic 
TABLE 1- PCP core and au xiliary medical directives 
Epinephrine (nebul ized) 
may use their clinical judgement to determine the patient's symptoms 
were from another cause (e.g. chest wall pain), and therefore that treat-
ment is not initiated. 
SCO PES O F P RACTICE 
For each of the three designated scopes of paramedic practice in Ontario, 
there are core medical directives, which must be provided by paramed-
ics at that level , and auxiliary directives that are approved for use but 
which may not be implemented by individual services. 
Primary Care Paramedics (PCP) 
The majority of paramedics in Ontario are PCP, requiring at least two 
years of college education. To be competitive for entry to most paramed-
ic programs today, some po t-secondary education is required. In addi-
tion to clinical placements in various settings, the final semester of the 
program is a full time field placement with a certified paramedic acting 
as preceptor. See Table I for a brief overview of PCP medical directives. 
Medical Termination of Re uscitation (TOR) is a new protocol in 
20 II . The intention is to remove the significant risk that is associated 
with driving lights and siren by ceasing resuscitation when deemed med-
ically futile . Resuscitation i initiated and, based on patient condition, 
the paramedics may be required to contact a Base Hospital Physician 
(BHP) via phone to discu the clinical situation and request a TOR 
order, which is given (or not) at the BHP 's discretion . 
The provincial stroke bypass protocol demonstrates how rapid pre-
hospital as essment by EMS can be of significant benefit to patients. Pa-
tient presenting with a probable cerebrovascular accident (CVA) should 
be brought directly to the nearest designated stroke centre, 'bypassing' 
the nearest ED. The intent i to get patients that fit the protocol crite-
Continuous Positive Airway 
Continuous Positive Airway Pressure 
Dextrose (intravenous) 
Semi-Automatic External Defibri llation Supraglottic airway 
IV access & 0.9% normal saline 
Nausea & vomiting Dimenhydrinate 
Termination of Resuscitation Medical and traumatic cardiac arrest protocols 
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TABLE 2- ACP core and auxiliary medical directives 
Note: All PCP skills are included in ACP skill sets (with the exception that some auxiliary PCP skills are core ACP skills, and some shared skills 
havedifferent indications) 
' ' 
- . - ~ .. ~ -,. ... 
·-
.,.'.'• ~~:- -',~ ~% .~~.4';:~~~~~:~.:.!i'1,5"~f~ :·_.; •4. ~ '~ :••.[: V-•~;t.·:~.~. :.~;!, • :/."~$.:~~: :~· <: :. ~: 
. :~ ~J. ~_,~__.~~~ ,..t;'__._,.!!>J!.k':.. .. .l ~~~-"'-"- ~ .•• :'J 1 ._..._.,._,."\~.t,.-;....,. .... •. ,_ ... _.t">_-. ,.y.nt ~·- ,.._ ~- .. 
Cardiac ischemia Morphine 
Cardiogenic shock Dopamine 
Symptomatic bradycardia Atropine, *transcutaneous pacing & *dopa-
mine 
Tachydysrhythmias (non-sinus) Yalsalva, *adenosine, *amiodarone/lidocaine, 
*synchronised cardioversion 
Seizure Midazolam 
Opiate overdose *Naloxone 
Hypoglycemia Dextrose (intravenous) & glucagon 
Fluid administration IV & pediatric intraosseous lntraosseous (adult) & central venous access 
device (pre-existing) 
Airway management Naso- or orotracheal intubation Supraglottic airway & *cricothyrotomy 
Tension pneumothorax *Needle thoracostomy 
Pain management (specific indications) Morphine & fentanyl 
Airway obstruction Removal with laryngoscope & Magill forceps 
Cardiac arrest Manual Defibrillation, epinephrine, 
amiodarone/lidocaine 
Return of Spontaneous Circulation Dopamine 
Combative patients *Midazolam 
Procedural sedation (intubation, pacing) Midazolam 
* Attempts to patch to a base hospital physician required before performing this skill. See [ 11] for more information. 
ria rapidly assessed by neurologists and CT scanned so that occlusive offered by the Omge Academy of Transport Medicine (see [7] for fur-
strokes can be treated with the thrombolytic tPA (Tissue Plasminogen ther information). CCP have a very broad scope of practice, including all 
Activator). ACP controlled acts and many that are CCP unique (e.g. chest X-ray and 
Some regions have also implemented STEMI (ST (segment) Elevat-
ed Myocardial Infarction) bypass protocols, based on the fact that para-
medics at most EMS services are trained to obtain and interpret 12-lead 
ECGs for ST segment changes. If the patient falls within the protocol 
criteria, the paramedics 'patch ' directly to the interventional cardiolo-
gist, who can then direct the crew to bypass the ED and bring the patient 
directly to the catheterization lab for angioplasty. Unlike the stroke pro-
tocol, STEMI bypass is not province-wide as far fewer hospitals have 
the necessary resources. 
Prehospital acquired 12-lead ECGs are listed as a class I recom-
mendation in the American Heart Association guidelines, having been 
shown to decrease door-to-need le time.4 Additionally, interpretations are 
usually obtained before treatment has been initiated and may demon-
strate findings that hospital ECGs do not, such as ST segment changes 
or arrhythmias that may have resolved.5 
Advanced Care Paramedics (ACP) 
PCP can later apply to an ACP certificate program, usually after writ-
ing entry examinations. Many programs also require prior work experi-
ence as a PCP (e.g. Fanshawe College requires 4000 hours within the 
last three years6). The ACP scope of practice includes all the controlled 
acts available to PCPs, along with a broad suite of additional delegated 
acts; however, not all EMS services employ ACPs. See Table 2 for a 
brief overview of ACP delegated acts. 
Critical Care Paramedics (CCP) 
ACPs with flight-medic certification can apply to the CCP program 
lab value interpretation, blood product administration, many more drugs 
including thrombolysis). 8 A BHP is always on duty to provide on-line 
medical direction for CCPs. These paramedics are primarily employed 
doing critical care land and air transfers, or in the case of the helicopters, 
for critical calls or locations that can 't feasibly be serviced by land am-
bulances (e.g. Pelee Island). 
EMS OPERATIONS 
Central Ambulance Communications Centers (CACCs) 
Whi le paramedics have authority over patient care, CACCs have au-
thority over ambulance movements. Communications Officers at CACC 
act either as 911 call-takers or as ambulance dispatchers . 
Dispatchers are responsible for ensuring timely EMS service and 
maintaining response capacity. They track all ambulances in their zone, 
and as units are dispatched to calls, other units are moved to cover the 
area of responsibility. The dispatcher must maintain constant awareness 
of all resources, and liaise as needed with other emergency services and 
hospitals. For this to be possible, ambulance movements need to be 
tightly linked to CACC 
The ongoing acute-care bed shortages in hospitals have bad a sig-
nificant impact on EMS services, as paramedic crews with low-acuity 
patients may end up on ' stretcher delay ' for hours waiting to transfer 
care. This is particularly a problem in urban areas, and results in reduced 
emergency coverage. 
The recent growth in private patient transfer companies has led to 
some confusion for other health care workers, who may expect an ambu-
UWOMJ I 81 :1 I Spring 2012 7 
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lance to transfer patients on both inbound and return trips. Due to the 
demands on the ystem di scussed above, it is rare today for non-acute 
transfers to be done by EMS. In any patient transfer by ambulance, acute 
or non-acute, the EMS crew must transfer care and return immediately 
to emergency coverage, their primary duty. 
Allied Emergency Services 
Fire personnel province-wide are responsible for rescue and extri-
cation. Many fire services also have tiered response agreements with 
local EMS whereby they are di spatched to certain high-acui ty call s to 
decrease average response time (as their base may be c loser to a call) 
and provide manpower to the two paramedics. lt is important to note that 
paramedics maintain overall control of care as their medica l tra in ing far 
exceeds that of fire personnel. 
Police officers and paramedi cs also work together regularly, a lthough 
police rarely arrive specifically to assi tin patient care. They are particu-
larly important for the safety of both the patient and emergency person-
nel when dea ling with combative patients or those with mental health 
issues, as they have the power to detain under the Mental Health Act or 
use restraints. 
Air Ambulance 
Air ambulances can either be requested immediately by the CACC 
receiving the 9 11 call , or by on-scene paramedics based on a series of 
operational and clinical criteri a.9 The pilots fi r t determine whether it i 
safe to make the fli ght; only then do the fli ght paramedics receive infor-
mation about the call. 
One major advantage of the air ambulance is in trauma, as it's able 
to rapidly transport patients from rural areas to a hi gh-level trauma cen-
tre.10 In Ontario the air ambulance can also perform ' modifi ed scene 
calls,' where a critical patient that bas successfull y reached the nearest 
ED is met at the hospi tal by the helicopter. The fli ght paramedics can 
then assume care from the ED staff and bypass to a trauma centre. 
CONCLUSION 
Ambulances often arri ve at scenes of chaos. Paramedics, with the assist-
ance of, CACC, medical directors, and many other factors, manage to 
restore some form of order and transport those requiring medi cal care 
to the waiting ED staff. Hopefu lly, this primer has managed to have 
success full y increased the reader 's understanding of the unique roles of 
EMS and paramedi cs in Ontario's hea lthcare system, as well as some 
of the unique challenges that mnst be faced in responding e ffecti vely to 
medical emergencies outside of the hospi tal environment. 
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FEATURE ARTICLE 
Painless amusement: the case of a man with 
schizophrenia presenting to the emergency 
department 
Paul A. Kudlow (Meds 2013), BSc. Daniel James (Meds 2013) MA, BA, BSc. 
Faculty Reviewer: Dr. RogerS. Mcintyre, MD, FRCPC (Department of Psychiatry, University of Toronto) 
Schizophrenia, a severe mental illness affecting an estimated 0.7% of the world's population, is characterized by myriad symptoms, broadly including derangements in cognition, perception, and 
emotional responsiveness.1 Along with these broad alterations, pain in-
sensitivity, or hypoalgesia, has been reported in schizophrenia since the 
early 20th century.2•3 Despite these early and ongoing case reports, little 
progress has been made to elucidate the underlying mechanisms driving 
this peculiar symptomatology. Herein, we explore a recent case report 
describing a patient with schizophrenia presenting with a si lent acute 
abdomen. Following this, we review the extant literature examining the 
underlying pathophysiology of hypoalgesia in schizophrenia. We con-
clude by proposing a novel mechanism to explain such an effect, as well 
as offer clinical recommendations to emergency physicians regarding 
appropriate management of severely mentally ill patients presenting to 
the emergency department. 
In this recent case report, we examine Mr. T, a middle-aged man with 
schizophrenia, who despite a perforated gastric ulcer and an active upper 
gastrointestinal bleed, presented without pain, abdominal rigidity, or an-
orexia.4 Mr. Twas a cachectic, disoriented male, taken to the emergency 
department. His vital signs were stable on arrival. Psychiatry confirmed 
schizophrenia and risperidone was started. The morning after admission 
to Psychiatry, he was tachycardic, hypotensive, hungry, but not in pain. 
Abdominal examination was benign, but CT found free air under both 
hemidiaphragms. He was taken for emergent exploratory laparotomy. 
The peritoneal fluid was purulent, and the stomach contained two perfo-
rated pyloric ulcers. The gastroduodenal artery was bleeding actively. 
Mr. T underwent corrective surgery, and was discharged from hospital 
in stable condition. 
In this case, Mr. T experienced a silent acute abdomen. Although 
extremely rare in the general population, a painless acute abdomen, as 
well as other insensitivities to physical sensations, is not as uncommon 
in psychotic patients. In a study of79 patients with psychosis, 21.4% of 
those with acute perforated ulcers and 36.8% of those with acute appen-
dicitis presented without any complaint of pain.5 Not surprisingly, this 
atypical presentation often leads to dangerous misdiagnosis, resulting in 
higher rates of morbidity (56% in patients with schizophrenia vs. 16% 
in the population as a whole) and mortality (4% in patients with schizo-
phrenia vs. 1.8% in the general population).6 Moreover, pain insensi-
tivity may help to explain why individuals with schizophrenia are less 
likely to complain of physical symptoms related to diabetes, arthritis, 
infectious disease, etc.6 As reported in this case, instead of the classic 
sign of pain, patients with schizophrenia often present with worsening 
positive symptoms, including increasing severity of hallucinations, de-
lusions, etc.7 
How do we explain the hypoalgesia experienced by Mr. T and other 
similar patients with schizophrenia? One tactic of inquiry is to explore 
mechanisms in other medical presentations where pain insensitivity is 
present. For example, certain stressful events, such as traumatic inju-
ries are known to result in transient hypoalgesia secondary to increased 
endorphin production.8 It has been postulated that increased levels of 
endorphins may account for decreased sensitivity to pain and other 
symptoms of schizophrenia.4 However, no such correlation between hy-
poalgesia and levels of endogenous opioids have been found in patients 
with schizophrenia.9 Other more recent hypotheses have utilized the re-
cent advances in our understanding of the neurobiology of schizophre-
nia to explain the hypoalgesic effect. Schizophrenia is known to involve 
dysfunction of the dopamine, glutamate, and more recently discovered 
cannibinoid systems. 1•10 These neurotransmitters have also been shown 
to be integral to the modulation of pain perception.11 Some investigators 
have postulated that certain neurotransmitter dysfunction seen in schizo-
phrenia, particularly in the dopaminergic and cannibinoid systems, may 
underlie the deficits in pain perception. 15 However, the evidence is lim-
ited by small sample sizes, generalizabi lity, and relatively inconsistent 
data. 15 Further research is needed to elucidate causation between the 
broad neurotransmitter dysfunction seen in schizophrenia and the spe-
cific hypoalgesic effect seen in this case. 
Here we move away from the neurobiological explanations and of-
fer a novel explanation that seeks to unite some of the known neuro-
psychological perceptual deficits in schizophrenia with the hypoalge-
sic effect seen in this case. We began by re-examination of the "first 
rank symptoms" originally proposed by psychiatrist, Kurt Schneider 
( 1887- 1967). 12 First rank symptoms, now mostly re-classified as "posi-
tive symptoms," can be broadly characterized by the feeling of being 
controlled by an external force . This often manifests in the patient with 
frank hallucinations and delusions. In 2000, Blakemore et al. published 
an interesting seminal work that correlated the severity of first rank 
symptoms with the unique ability to tickle oneself. 13 Individuals suf-
fering from the most severe hallucinations and delusions were found to 
be more likely to have an ability to tickle themselves . Based on these 
results, researchers proposed a feed-forward model : in normal individu-
als, a central efferent copy of a motor command (tickling command) 
is actively compared to a re-afferent signal (tickling sensation) arising 
from an individual 's action. The signals are compared in a signal "inte-
grator." The integrator actively compares the difference between the two 
signals. If none exist, the signals cancel out, and we perceive nothing (as 
is the case when normal individuals try to self tickle) . Yet once there is 
a difference, the integrator generates a signal, which we perceive as a 
sensation. Given that patients with schizophrenia have an ability to self-
tickle, yet possess intact efferent and re-afferent pathways, investigators 
postulated that these individuals may have a problem with the central 
"signal integrator" - causing it to generate erroneous signals . This for-
ward mechanism for knowing is thought to underlie our cognitive ability 
to differentiate between self-produced and externally produced stimuli 
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- an abi lity thought to be impaired in schizophrenia. 
This model was later validated by a recent study completed by Voss 
et al. Investigators found that patients with schizophrenia made global 
perceptual errors - often fa iling to associate their own actions with ex-
ternal events leading to persistent misinterpretation of endogenously and 
exogenously driven stimuli .14 Moreover, severi ty of positive symptoms 
in the patients was correlated with increasing amounts of global percep-
tual errors. 
Intriguingly, in the case of Mr T., as well as in other similar case re-
ports6.8·1S, si lent acute abdomen often presents in the context of increas-
ing severity of positive symptoms. In the past, authors postulated that the 
onset of an acute abdomen (overwhelmingly painful stimulus) triggers 
increasing positive symptoms (hallucination and delusions). Yet given 
the model delineated above, it is also possible, and logical to conclude 
an opposite temporal relationship. A high degree of positive symptoms 
in mental illness may lead to global perceptual errors - this in tum may 
be responsible for varying degrees of pain insensitivity. 
Applying the model to the case, Mr. T may have a deficit in his cen-
tral "signal generator," causing him to misinterpret the external pain 
stimulus of his acute abdomen as that of a stimulus he was creating him-
self. Thus, similarly to a normal individual attempting to tickle himself, 
Mr T simply did not feel or react. We propose that this hypoalgesia could 
be secondary to the global perceptual deficits typified in schizophrenia. 
This is in contrast to the primary mechanisms as previously described. 
More research however needs to be done in this area to fully elucidate 
how global errors in the feed forward mechanism may lead to hypoalge-
sia as seen in schizophrenia. 
For example, a study, similar in design to the studies completed by 
Blakemore and Voss et al. could be undertaken to examine whether the 
ability to self-tickle (a validated proxy for global perceptual errors) was 
associated with varying degrees of pain insensitivity. If the model pre-
sented in this discussion were valid, degree of pain insensitivity would 
increase with higher responses to self-tick le. Extending this model 
one step further, since self-tickle has been postulated to be secondary 
to severity of positive symptoms1\ patients with the highest degree of 
positive symptoms would be expected to have the greatest amount of 
pain insensitivity. Reduction of positive symptoms with administration 
of anti psychotics would therefore be expected to reduce degree of pain 
insensitivity. A study completed by Jochum et al. , examined the effect 
of antipsychotics on the perception of pain in schi zophrenia. 16 Simi larly 
to previous reports, investigators confirmed varying degrees of hypoal-
gesia in patients with schizophrenia. Accordingly, three days following 
administration of antipsychotics, pain perception differences became 
less apparent between patients with schizophrenia and healthy control . 
The effect size was small (less than 5%). However, thi s wa likely con-
founded by the short measurement window of three days. Future studies, 
extending the treatment mea urement window, may find a larger effect 
size. 
ln conclusion, physicians must be aware of the potential atypica l pre-
sentation of a patient with schizophrenia in pain . This of course has im-
plications for triage, assessment and treatment in the emergency depart-
ment. Emergency physicians should maintain a high index of su pic ion 
for acute abdomen and other painful conditions in seriously mentally 
ill patients presenting with a high degree of po itive symptoms or any 
indication of decreased pain sensation. Although a thorough head-to-toe 
physica l exam is essential, in these patients it can be misleading. There-
fore, as evidenced by the case of Mr. T, close scrutiny of any laboratory 
investigations or imaging studies will help to ensure that these challeng-
ing patients receive appropriate care. 
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ABSTRACT 
Hepatocellular carcinoma is a rare, yet devastating diagnosis with lim-
ited treatment options. For selected patients, transarterial chemoembo-
lization (TACE) is a therapeutic choice which allows for treatment that 
is minimally-invasive, directed, and reduces mortality. Nonetheless, it 
represents an innovative approach to cancer treatment and investigat-
ing its efficacy from both a biomedical and biopsychosocial perspective 
warrant discussion. 
BACKGRO UND: 
In Canada, primary liver cancer (PLC) is an uncommon diagnosis with 
an incidence rate of 2.2 I I 00 000 individuals and approximately 1950 
new cases were diagnosed in Canada in 2011. 1 Current statistics from 
the Canadian Cancer Society indicate that the incidence rate of PLC has 
increased by an average of 2.9% with an associated increase in mortal-
ity over the period spanning from 1998-2007.2 Major risk factors for 
PLC in Canada include alcohol-related cirrhosis, hepatitis C virus, and 
hepatitis B virus. More recently, type 2 diabetes mellitus has been linked 
as an risk factor for hepatocellular carcinoma.3 In developing nations, 
the consumption of foods containing aftatoxins and parasitic infections 
such as schistosomiasis and liver flukes represent additional risk factors . 
Hepatocellular carcinoma (HCC) accounts for 85-90% of PLCs and 
once detected, treatment options are often limited. This is due to the fact 
that there is currently no PLC screening test and the signs and symptoms 
of PLC are vague, non-specific, and often do not manifest until the dis-
ease is locally advanced or has metastasized. The symptoms include: 
nausea, vomiting, loss of appetite, jaundice, hepatomegaly, weight loss, 
and fatigue . It is estimated that the median survival time for untreated 
HCC is less than 5 months and the 5-year relative survival rate after a 
diagnosis ofPLC is approximately 18% in Canada.2· 4 
After a diagnosis of HCC, the main therapeutic options are as follows: 
Resection - for localized tumour in a liver that has retained ad-
equate synthetic function . As much as 75% of a liver may be re-
sected in an operation. Many patients are ineligible for resection 
due to the size or number of liver lesions present or based on the 
fact that the lesions have invaded into the liver 's blood supply. 
Transplant - for non-metastatic disease with an appropriately 
matched donor. This approach requires lifelong immunosuppres-
sion and is limited by the supply of available donor livers . 
Other - cryosurgery, radiofrequency ablation, chemotherapy, radia-
tion therapy. This category involves many cutting-edge therapies 
which are sti ll under investigation for their efficacy. 
TRANSARTERIAL CHEMOEMBOLIZATION: 
Transarterial chemoembolization (TACE) is a treatment for unresect-
able HCC which fits into the latter category. It is performed by an in-
terventional radiologist and involves percutaneous image-guided access 
to selectively deliver a chemotherapeutic agent to the blood vessels 
supplying a tumour. In this way, a tumour may be specifically targeted, 
minimizing the systemic effects of chemotherapy (and the associated 
side effects) while stunting or arresting tumour growth. It is a minimally 
invasive approach that has been shown to improve survival for carefully 
selected patients with unresectable HCC.5•7 Patient selection is com-
monly based on prognostic scales such as the Child-Pugh score8, Model 
for End-Stage Liver Disease (MELD) 9, or the Milan criteria 10 which 
incorporate various markers of liver function, tumour characteristics, 
and comorbidities. 
A PATIENT'S EXPERIENCE 
Patient X is a 63-year-o ld gentleman with biopsy-proven HCC likely 
secondary to hepatiti s C and alcoholic cirrhosis. At the time of presenta-
tion, there were no signs or symptoms of decompensated liver disease. 
Initial bloodwork showed a mild elevation in transaminases and elevat-
ed ferritin . Other liver studies were unremarkable. 
His initial imaging studies consisted of an abdominal ultrasound and 
contrast CT which showed a 4.2 em rounded mass with evidence of 
arterial enhancement (see Figure 1). A number of additional "suspicious 
lesions" were identified within the liver. Lymphadenopathy was also 
present in the periaortic area. These findings were suggestive of HCC. 
The patient's case was then reviewed at the Liver Transplant Listing 
Rounds by the hepatology team and transplant teams at London Health 
Sciences Centre. Based on their opinions, the patient bad a MELD score 
of 7 (low risk of mortality); however, based on location and arterial in-
volvement, the tumours were not amenable to resection. Furthermore, 
based on the number of lesions and size of the dominant lesion (the Mi-
lan criteria) the patient was ineligible for transplantation. His continued 
intake of alcohol was also a contraindication to transplant. The decision 
to undergo TACE in order to control tumour growth and down-stage the 
tumour was made with the patient 's consent. 
PROCEDURE: 
Initial Procedure 
Access to the common iliac artery was obtained via the right common 
femoral artery through ultrasound guidance and the Seldinger technique. 
A series of angiograms were then performed which demonstrated tu-
mour growth when compared to the initial imaging studies. In this case, 
the DEB-TACE chemoembolization delivery system was utilized. This 
consists of drug-eluting beads (DEB) loaded with doxorubicin chemo-
therapy. These beads are mixed with Lipiodol, a contrast agent, and 
then targeted at the tumour via angiography. Aside from a vasovagal 
incident, the patient tolerated the procedure well. A post-procedure CT 
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Figure 1: Initial CT showing large liver lesion 
Figure 3: CT showing viable tumour in region previously treated by 
DEB-T ACE 
showed adequate tumour coverage (Figure 2) although residual tumour 
was noted and a repeat DEB-TACE procedure was planned. 
Repeat Procedure 
Prior to the repeat procedure, an additional CT was conducted, which 
showed areas of arterial enhancement suggesting viable tumour (Figure 
3) as well as multiple nodules representing new tumour foc i (Figure 4) . 
The pati ent underwent a second DEB-TACE procedure in a similar fas h-
ion to the initi al procedure. He tolerated the procedure well although a 
second-degree Mobitz Type I heart block and ri ght bundle branch block 
were fo und incidentall y which were deemed not to req ui re treatment. 
Repeat CT will be conducted approximately I month afte r this last pro-
cedure to assess the tumours. 
Post DEB-TACE #2 
Figure 2: Post procedure CT showing hyperdensity consistent with 
DEB-TACE treatment 
Figure 4: CT showing new areas of tumour growth 
PATIENT'S EXPERIENCE: 
The pati ent was agreeable to speaking about hi s condition and was in-
terviewed with his wife prior to his second DEB-TACE procedure. In-
formed consent was obtained . It was a unique opportunity to gai n insight 
into the patient's thoughts regarding hi s treatment experience. The con-
versation was guided by the National Research Corporation 's &-dimen-
sions of Patient Centered Care. 11 Major highlights of the conversation 
were as fo llows: 
The patient often felt that he was not actively informed or involved 
in the decision making regarding his care. He was particularly upset by 
the fact that li ttle contact was made with him to discuss his diagnosis, 
prognosis, and treatment option . He stated that it was, "a constant feel-
ing of not knowing what I was getting into", and his wife confirmed that 
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many of their questions were not addressed until her husband arrived for 
his first DEB-TACE procedure despite the fact that his case had been 
reviewed by the hepatology and transplant teams. 
Approximately S months elapsed between the patient's ultrasound 
scan and his first DEB-T ACE procedure. The patient and his wife could 
not comment directly on whether they felt this wait was appropriate or 
not. However, they were pleased with how quickly things progressed 
from the time they initially met with the interventional radiologist and 
the first procedure (approximately 3-weeks). 
His experience of the actual DEB-TACE procedure was positive and 
the patient was impressed by how well he tolerated the procedure. He 
stated that post-op pain was minimal ("I shook it off quickly") and that 
he was able to work within 10 days. He had no qualms about consenting 
for the repeat procedure and was surprised that he had minimal post-
procedure complaints. These were mainly "weakness" and "pain" which 
disappeared within 3-weeks. 
Although not curative, the patient was optimistic about the prospects 
of his treatment. Given his lack of pre-op symptoms, it is difficult to 
speculate over the survival benefit conferred by the DEB-TACE treat-
ments; however, he remains asymptomatic after completing both rounds 
of therapy. Follow-up CT will be scheduled for the coming months to 
assess the success of the latest procedure. 
CONCLUSIONS: 
TACE is a viable option for patients with HCC who have exhausted 
other treatment measures. This investigation highlights the fact that the 
success of a procedure should be measured by both its clinical outcomes 
and the patient 's overall satisfaction with their treatment experience. Re-
gardless of complexity or efficacy, every procedure is subject to the same 
core principles of patient care, with communication being paramount. 
This case highlights what can occur if these channels are severed, lead-
ing to patient dissatisfaction despite a positive clinical outcome. TACE 
requires the coordination of many different healthcare professionals and 
teams, and including the patient in all discussions should be the norm if 
we aim to maintain a high standard of care. 
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INTRODUCTION 
Contrast-enhanced echocardiography (CEE) is a method of echocar-
diography that utilizes the echogenicity of specific contrast media to 
greatly increase the contrast obtained between blood and tissue.1 The 
concept, while over four decades old, has recently had increa ed atten-
tion in the clinical and preclinical realms of cardiovascular research due 
to advances in technology that increase its utility. 
EXPLANATION OF FUNCTION 
Ultrasound functions by detecting the different den ities of tis ues in the 
body based on their different responses to sound energy. CEE derives 
its superior resolution from the use of contrast agents carried in the cir-
culation that respond uniquely to sound energy. It was first realized by 
Gramiak and Shah in 1968 that gas suspended in the blood stream alone 
has advantages for imaging because the density differential between gas 
and liquid phase provides optimal echo feedback patterns.2•3 However, 
early contrast agents were too large to navigate through the capi llary 
network of the lungs to the systemic circulation, and would prematurely 
diffuse into tissues.3 Hence, newer agents were developed to be both 
smaller and more stable. The so called " second generation" contrast 
agents were composed of microbubbles of high density gas (usually 
fluorocarbons) , encapsulated with a lipid or albumin coat. These mi-
crobubbles undergo volumetric osci llations under the pressure changes 
induced by the ultrasound transmitter. Thi vibration produces energy 
that can be picked up by the transducer and converted into an image.4 
Microbubbles are very small , simi lar to the size of red blood cells, and 
are able to navigate through caP.illary systems without becoming lodged . 
They are strong enough to withstand " inertial cavitation," that is, large 
oscillations in energy from the ultrasound that can destroy the bubbles.5 
Older contrast agents could on ly enable CEE to image the right side 
of the heart, limiting their role to the investigation of intracardiac or 
intrapulmonary shunts. The second generation agents opened a door for 
a new role ofCEE. 5 
With advances in contrast agents, the ultrasound hardware technol-
ogy had to adapt as well. Current CEE uses harmonic imaging that was 
developed as a way for contrast-specific imaging modalitie to use lower 
transmission power than that used for non-contrast imaging. This is re-
quired because high transmission power causes destruction of the micro-
bubbles and impairment of tissue signals of the myocardium.6 Detection 
methods now preferentially detect the harmonic signals given off from 
the microbubble oscillations, minimize the signals from tissues, and pro-
vide a very high signal-to-noise ratio.5 
ADVANTAGES AND DISADVANTAGES 
The primary advantage of CEE technology lies in its superior image 
quality when compared to native echocardiography, leading to more ac-
curate measurements of entricular volumes, better detection of thrombi 
or hypertrophy, and improved wall motion assessment. For example, 
it bas been found that native ecbocardiograpby consistently underes-
timates left ventricle (LV) volumes when compared to magnetic reso-
nance imaging (MRJ) tudies because it does not have the capacity to 
image the trabeculation of the ventricular endocardium when measuring 
volume. CEE results have been found to be equivalent with MRI due to 
the ability of contra t agent to include the fine details of cardiac anat-
omy.6 The uperior imaging capabilitie of CEE are also demonstrated 
in patients with poor ba eline quality native ecbocardiograms, a number 
that can range from I 0-15% of those scanned. To our knowledge, all 
studies conducted ha e found better results after CEE in these patients. 6 
Another advantage of CEE i reproducibility of re ults. Native echo-
cardiography has been criticized for high variability of measurements. 
This has led to a shift in patients being referred for expensive and time-
consuming te t like Multi Gated Acquisition Scans (MUGA) and MRI 
studies. CEE has reproducibility on par with MRJ, and is much less 
expensive. 8 Even for technically difficult studies, such as stress echo-
cardiography \ here inter-ob erver agreement can range from 43-100%, 
CEE significantly improve the confidence of the interpretation, and 
therefore, the reproducibility. 9 
The main limitation to EE technology has been concerns regard-
ing adver e event with the u e of contrast agents . In 2007, the FDA 
is ued Black Box warning to CEE contra t agents after reports of fa-
talities from cardiopulmonary reaction in at least 18 patients during 
pro edures. 10 These afety concerns lowed adoption of the technology, 
and po ed question about the future of CEE in the ecbocardiograpby 
community. However, it should be noted that the risks of adverse events 
are very low. ompari ons of the mortality rates of various cardiac pro-
cedure shows that mortality from CEE is (I : 145,000) excessively small 
compared to coronary angiography (I : I 000) or even exercise electrocar-
diography (I :2500) . 10 The FDA currently recommends close monitoring 
of vitals and G for at least 30 minutes after administration of contrast 
agent . 11 This monitoring time may be difficult for busy echo labs at 
tertiary care centres, negating many of the time-saving benefits of echo-
cardiography as an imaging modality. 
INDICATIONS OF USE 
A discussed above, CEE provides greater contrast between blood and 
tissue.12 Therefore, organ border delineation may be determined with 
greater resolution and accuracy. This is often applied to endocardial 
border delineation, which allows for a better determination of wall 
thickening or other wall abnormalities.13 Contrast enhanced ultrasound 
may al o be used to determine the perfusion of tissue. 14•15 As well it may 
be used to estimate the volume of blood in a given organ or section of 
tissue through the quantification of bubbles present and the extrapola-
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tion to a representative volume of blood. 16 
With these concepts in mind and evaluation of the current clinical 
evidence of usage, the American Society of Ecbocardiography (ASE) 
published a consensus statement outlining in detail the evidence-based 
application of CEE. 17 The ASE recommended that CEE should be con-
sidered in the following clinical scenarios: 
assessing left ventricular systolic function when quantitative vol-
umes are required and during stress ecbocardiography 
evaluating the left ventricular apex 
evaluating mechanical complications of a myocardial infarction 
evaluating a potential cardiac mass 
evaluating perfusion (i .e. enhancing Doppler in the systemic cir-
culation). 
It should be noted that the above clinical scenarios are where CEE 
may be considered, however, CEE should not be used routinely in these 
scenarios. Rather, CEE should be used when non-CEE is not viable. 
More specifically, CEE should be used if two contiguous left ventricu-
lar segments are not seen on non-contrast images. 17 Also of note, since 
the publication of the consensus statement in 2008, the efficacy of the 
recommendations bas been evaluated and found to be highly benefi cial 
and safe in practice. 21 CEE may be particularly beneficial with obese 
patients as image quality is usually poorer with non-CEE. 17 
FUTURE DIRECTIONS 
New Applications in Assessing Myocardial Flow 
CEE is currently being used to assess myocardial perfusion, but 
novel applications to its use are being considered. The first is bedside 
CEE that could be used in emergency departments to aid in the work-
up of patients presenting with chest pain. Not only could this identify 
higher risk patients and provide expedited treatment with the most ap-
propriate modality, but it could obviate the need for other expensive or 
invasive testing. 5 CEE could also be used in patients with recognized 
ST elevation myocardial infarctions to gather valuable wall motion in-
formation for prognostic purposes. 18 Finally, the power of CEE for as-
sessing perfusion has been recently used in new diagnostic situations 
to evaluate patients with ischemic symptoms caused by vasoregulatory 
mechanisms, as opposed to total obstruction of epicardial vessels. This 
is especially useful for gaining prognostic information in patients that 
suffer from diabetes, hypertension, or dilated cardiomyopathy, and guid-
ing therapy. 19 
Peripheral Vascular Imaging 
The ability of CEE to accurately delineate ventricular borders has 
been further applied to the identification of vascular borders. Recently, 
CEE has been used to assess vascular disease due to its ability to evalu-
ate the vasa vasorum, the system of vessels that penetrate and supply 
blood to the walls oflarge vessels of the body. In atherosclerotic disease, 
expansion of the vaso vasorum bas been shown to be integral in the 
development of plaques, macrophage accumulation and plaque rupture. 
2° CEE may play a future role in monitoring the development of the ath-
erosclerosis, and stratifying patients for new therapies designed to slow 
the later stages of the disease. 5 
Targeted Microbubbles for Specific Imaging 
Many novel applications derive from the molecular targeting of 
microbubbles. Targeting molecules, such as ligands or monoclonal an-
tibodies, may be conjugated to the surface of microbubbles. 22 These 
targeting moieties may then bind to their target, localizing more micro-
bubbles to the area of interest (where the receptor of interest is located) 
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and enable the non-invasive ultrasonic imaging of this location . For ex-
ample, inflammatory markers/receptors may be targeted to illuminate 
the precise location. 23 In prec linica l models, microbubbles have been 
targeted to inflammatory regions, atherosclerosis and cancer. 23•24·25 Fur-
thermore, this presents the potential to use microbubbles to specifically 
target cells expressing certain receptors, allowing the deli very of drugs 
or other materials to these specific cells. 26 
Ultrasound-Mediated Gene and Dn1g Delivery 
Using targeted or non-targeted microbubbles, drugs or genes may be 
delivered to cells of interest. 26 Microbubbles are loaded with the drug 
or gene of interest and upon imaging, high frequency ultrasound is de-
li vered to the area of interest to burst these bubbles and transiently cre-
ate pores in the surrounding cells allowing for the intracellular delivery 
of the microbubbles ' contents. 27 This technique is especially suited for 
delivery to endothelial cell s as they are most easily accessible from the 
blood stream where microbubbles predominate. Therefore, they can be 
used to either destroy the endothelial cells (eg. eliminating the blood 
supply to cancer cells) or promote angiogenesis in the case of vascular 
disease (eg. promoting the growth of new blood vessels will increase the 
perfusion of under perfused ti ssue due to occlusion). 28•29 
Centres are increasingly adopting CEE technology for the advan-
tages it offers, especially as the safety of the procedure becomes real-
ized. Clinical and research settings alike can benefit from the current 
applications of CEE, and the many more promising avenues for its use 
on the very near horizon. 
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The new OACs are here ... don't forget warfarin just 
yet! 
Yin Hui (Meds 2015) 
Faculty Reviewer: Dr. Michael J. Rieder, MD PhD FRCPC FAAP FRCP(Giasgow) (Departments of Paediatrics, 
Physiology & Pharmacology and Medicine) 
Cardiac arrhythmias are health problems that become more com-mon as people age, with atrial fibrillation (AF) being the most common cardiac arrhythmia. AF can occur due to some diseases, 
certain toxins, or as an adverse consequence of procedures that cause 
pathophysiological changes. These in tum cause the electric signal in 
the atria to be disturbed, which leads to rapid and irregular contractions. 
Irregular heartbeats disturb the smooth laminar flow of blood, leading 
to pooling of blood in the left atria. The conventional view is that this 
stasis results in thrombi formation , mainly in the left atrial appendage.1 
These thrombi can travel to the left ventricle and be ejected to systemic 
circulation, causing stroke when travelling to the brain, or systemic em-
bolism when travelling elsewhere. The risk of stroke (per I 00 patient 
years) can be predicted with a simple and validated CHADS2 scoring 
system (Table 1).2 
The vitamin K antagonist, Warfarin, is the most common oral antico-
agulant (OAC) used to prevent stroke or systemic embolism in patients 
with AF. Warfarin works by inhibiting the production of clotting factors 
II, Vll, IX, and X, and vitamin-K-dependent proteins C and S.4 The inhi-
bition of these factors leads to a net effect of decreased thrombi forma-
tion, and 64% reduction in risk of stroke. However, this is accompanied 
by an increase in risk for bleedings To minimize the risk of side effects 
while maximizing efficacy, anticoagulation therapy must be monitored, 
typically by measuring the International Normalized Ratio (fNR) on a 
regular basis. The INR is an index of coagulation, with a normal value of 
0.8-1 .2. In most warfarin therapies, the target INR is 2.5, with an accept-
able range of 2-3 . Regular INR testing can be cumbersome, especially 
in the beginning of therapy, as patients need to have blood work done 
to establish an optimal dosing, at first every 2-3 days, then every week, 
and then every two weeks. Once an optimal maintenance dose is found , 
patients will continue to need INR measurements done every month for 
monitoring.6 
The loading and effective doses vary widely between patients tak-
ing Warfarin . This bas been attributed to a multitude of factors that af-
fect the pharmacokinetics of the medication . Warfarin is 99.5% protein 
bound, and therefore displacement by another highly protein bound drug 
can greatly alter its bioavailability and effect. Metabolism of Warfarin 
depends on several different enzymes, including the cytochromes 2C9, 
2Cl9, and 3A4.6 These enzymes are responsible for metabolism of many 
other commonly used medications, leading to drug-drug interactions. 
Interactions also exist with many commonly used vitamins and herbals .6 
Common dietary foods containing vitamin K, as well as cranberry juice 
and green tea, often will also affect the efficacy and safety of warfarin . 7 
Genetic polymorpbisms of the vitamin K receptor VKORC I and the cy-
tochrome CYP2C9 make predicting the effective dose and establishing 
maintenance dose even more difficult. 6 Routine genotyping to establish 
dosing has been shown not to be cost effective, although the cost as-
sumptions that this was based on may be dated .8 Finally, Warfarin has 
a half-life of approximately 40 hours, leading to effects of changes in 
dosing to be expressed several days later. Coupled with variabi li ty in 
a person 's everyday life, it can be difficult to determine the causes of 
changes in fNR. Difficulty in managing warfarin therapies have led to 
patients being within the therapeutic INR range on ly - 50% of the time.9 
In an attempt to overcome the challenges with Warfarin, both anti-
coagulant and antiplatelet agents have been evaluated. In 2003, ximela-
gatran (Exanta™, AstraZeneca) , a direct thrombin inhibitor, bas been 
approved in some European countries for use in prevention of stroke and 
systemic embo li sm for patients with AF, as well as for venous thrombo-
embolism (VTE) after orthopaedic surgery. It was the first OAC mar-
keted as a replacement for warfarin. 10 However, due to severe li ver tox-
icity discovered post-market, ximelagatran was withdrawn worldwide 
in February 2006.11 ln the ACTIVE-W trial , warfarin was compared to 
combination therapy with acetylsali cylic acid (Aspirin™, Bayer) and 
clopidegrel (Plavix™, Bristol-Myers Squibb and Sanofi-Aventis), with 
Warfarin proved to be superior in efficacy and safety.12 In the AMADE-
US trial , Warfarin was compared to idraparinux (Sanofi-Aventis), a sub-
cutaneous factor Xa inhibitor simi lar to fondaparinux , with idraparinux 
having significantly more bleeding events. 13 
More recently, several new OACs have been developed and brought 
to market. Dabigatran (Pradax™, Boehringer lngelheim), a direct 
thrombin inhibitor, rivaroxaban (Xarelto™, Bayer), a factor Xa inhibi-
tor, and apixaban (Eliquis™, Pfizer and Bristol-Myers Squibb), also a 
factor Xa inhibitor, has already been shown to be effective in prevention 
of VTE after orthopaedic surgery, joining the ranks of unfractionated 
heparins and low molecular weight beparins. 14 ln 2009, the Randomized 
Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial dem-
onstrated dabigatran to be superior to Warfarin in prevention of stroke 
and systemic embolism due to AF on the recommended dose of 150mg 
twice daily, and non-inferior when using II Omg twice daily for elderly 
patients or patients with reduced renal function. 15 Subsequently, the Ri-
varoxaban Once Daily Oral Direct Factor Xa Inhibition Compared with 
Vitamin K Antagonism for Prevention of Stroke and Embolism Trial 
in Atria l Fibrillation (ROCKET-AF) trial showed rivaroxaban to be 
non-inferior to Warfarin in managing high-ri sk patients at 20mg daily. 16 
Most recently, the completion of Apixaban for Reduction in Stroke and 
Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial 
showed that apixaban was non-inferior to Warfarin at 5mg twice daily.17 
While each trial has weaknesses, there is a general trend of improved 
efficacy and safety in their use. 
These new OACs boast long awaited qualities : few drug interac-
tions, virtually no dietary interactions, efficacy and safety not affected 
by genetic polymorphisms, quick onset, short half-lives ensuring quick 
offset, no need for laboratory monitoring, and improved safety profiles . 
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Specifically, hemorrhagic stroke and serious bleeding bad statistically 
significant risk reductions for all three agents. 15-18 
However, there are also proposed disadvantages associated with these 
agents both individually and as a group. Dabigatran caused potentially 
severe heartburn or reflux in II % of patients in RE-LY. 15 ROCKET-AF 
had several major weaknesses in the trial design, leading to uncertaintie 
about the true efficacy and treatment effect of rivaroxaban . Guidelines 
have yet to be deve loped for apixaban in regards to switching to and 
from warfarin, or holding for surgery at the time this article is written. 
As a group, there are numerous down ides to the new OACs as well. 
To begin with, Warfarin ha been used for the past 50-60 years gathering 
a large body of evidence and experience, whereas the new OACs come 
with very few studies and little clinical experience. For example, there 
is rea onably robust evidence for Warfarin u e in vulnerable populations 
such as pediatrics, whereas this population i routinely excluded in all 
of the trials involving the new OACs.19-21 In addition, many comorbidi -
ties were excluded by RE-LY, ROCKET-AF, and ARISTOLE, such a 
valvular AF, creatinine clearance <30 mVmin, and active liver disease. 
Given that the potential for significant adver e event in these excluded 
populations cannot always be extrapolated from existing data, caution 
should be taken in introducing new OACs to these patients. 
Second, the new OACs have no reliable measurement of effect. The 
sign of inefficacy is simply the occurrence or recurrence of stroke or 
systemic embolism. On the other hand, Warfarin 's regular need for INR 
monitoring can be beneficial. INR provides a urrogate marker of the ef-
ficacy of therapy. This allows Warfarin to be used in conditions exc luded 
by RE-LY, ROCKET-AF, and ARISTOTLE, because there is a monitor-
ing system available to adjust dose based on the INR. 
Third, as Warfarin has been used for more than 50 years, its long-
term efficacy and safety have been studied and well known . On the other 
hand the "oldest" new OAC, dabigatran, just came onto market in 20 I 0. 
Rivaroxaban and apixaban just concluded their landmark trials within 
the past year. A long-term study of dabigatran, the RELY-ABLE trial 
(NCT00808067), will evaluate its long-term efficacy and safety for a 
maximum of just 28 months after first use. 22 
Fourth , none of the new agents has corre ponding antidotes that have 
been shown to predictably and reliably rever e their effects. In com-
parison , Warfarin has a reliable reversal agent in situations of overdo e/ 
toxicity - vitamin K, with established reversal guide lines.6 For the new 
OACs, clinicians can use dialysis , fta h frozen pia rna, prothrombin 
complex concentrates (PCC), or recombinant activated factor VII (rf-
VII) in situations of bleeding, although the efficacy of any of these ap-
proaches have not been demon trated .23 Experts have deve loped a set 
of recommendations for treatment of anticoagulant associated bleeding 
for the new OACs. However, these recommendation are often ba ed on 
Criteria (one point each) CHAD 2 Score 
c Congestive Heart Failure 0 
H Hypertension I 
A Age >75 years 2 
D Diabetes Mellitus 3 
s Prior stroke or TlA (2 points) 4 
5 
6 
ASA Acetylsalicylic acid; OAC Oral anticoagulant 
anecdotes and their efficacy remains theoretical. 24 The lack of reliable 
reversal agents, combined with the lack of evidence for use in patients 
with poor renal function, leads to uncertainty of use in frail, elderly pa-
tients, especially those of poor health . 25 
Fifth, the short half-life of these new agents make them not fitted 
for patients who are non-compliant (due to forgetfulness or otherwise). 
These agents have half-lives less than 12 hours and reversible inhibitory 
effects_IS- 17 Missing one dose could significantly affect circulating drug 
levels and clotting factor inhibition, leading to changes in efficacy. How-
ever, no studies have been done to investigate this effect. 
Finally, the new OACs cost up to $300/month, which is significantly 
more expensive than Warfarin therapy and INR monitoring combined.26 
The Ontario Drug Benefit plan has yet to add these medications to its 
formulary for AF. Therefore, patients would have to pay out-of-pocket, 
or use a third party payer, if therapy is desired. High cost of the medica-
tions may also pose a barrier in incorporation into the hospital formular-
ies, since the cost would significantly affect the pharmacy budget. 
In light of current information, the new oral anticoagulants are an 
excellent alternative to Warfarin in certain situations. They offer highly 
desired benefits of convenience and safety. In a non-valvular AF adult 
patient who is often compliant, with no active liver disease or severe 
renal dysfunction, the new oral anticoagulants can offer a much bet-
ter medication experience. o far, only dabigatran is approved on the 
Canadian market for use in prevention of stroke and systemic embolism 
in patients with AF. Se era! major teaching hospitals are looking at, or 
have added dabigatran into their formularyY 
As head-to-head trial between the new OACs will not be beneficial 
for the parties involved, it is unlikely these trials will be conducted in 
the near future . Therefore, when given a choice, clinicians should use 
their clinical judgement to choo e the agent taking into account indi-
vidual patient condition , as well a known afety and efficacy data of 
each drug. A these new OACs are used and studied more often, clinical 
experience and e idence may provide new facet of their use. With the 
rapidly changing land cape, anticoagulation is certainly an area worth 
watching. For now, don't forget about Warfarin just yet! 
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The current role of focused assessment with 
sonography for trauma {FAST) in the ever-evolving 
approach to abdominal trauma 
Brennan Ballantyne (Meds 2014), Alden Ling (Meds 2014), Alexander Pazion is (Meds 2015) 
Faculty Reviewer: Dr. Roy W. Roebotham MD FCFP(EM) (Division of Emergency Medicine) 
BACKGRO UND 
Trauma i the leading cause of mortali ty worldwide, and is a leading 
cause of death in both men and women under the age of 35 Y Apart 
from the high incidence of mortali ty, trauma is responsible for leaving 
45 million people per year worldwide with moderate to severe di sabili-
ties. ' It is no surpri e that victims of traumatic events have ignificantl y 
better morbidity and mortality outcomes when treated at centres with 
designated trauma units, where there are hea lth care professional that 
have been trai ned in specific triage, di agnostic and treatment techniques 
to manage trauma patients. 3 
One of the main complicati ons leading to high mortali ty after trauma 
is exsanguination from injuries to organs of the abdomen. The li ver and 
spleen are the most common culprits, with the kidneys inj ured often 
as we ll. 4 Blunt abdominal trauma is most frequent ly cau ed by motor 
vehicle accidents involving both vehicle and pedestri ans. A minority of 
other causes include blows or fa lls in volving the abdomen.5 The evalu-
ation of abdominal trauma i one of the most challenging areas of acute 
trauma management because injuries may not manifest in the initial as-
sessment, physical fi ndings are often unreliable, the presence of other in-
juries causes d ifficult ies, and the patients can present with altered mental 
status from head injuries or intox ication. 6 Historically, blunt abdominal 
trauma was even more difficult to manage becau e practit ioner lacked 
the non-invasive and expedi ent imaging techniques that are ava ilable 
today. Non-therapeutic laparotomy was the primary method by whi ch 
trauma personnel uncovered signi ficant abdominal injury. However, 
laparotomy carrie a ri sk of compli cation (0.8-2.3%) and expo e the 
patient to the short- and long-term sequelae of the procedure. 7 There ha 
been a continuous search for accurate and ex pedient te ts that can detect 
occult bleeding and obviate the need for inva ive procedure , uch a the 
non-therapeutic laparotomy. 
DIAGNOSTIC PERJTONEAL LAVAGE 
The first report of the diagnostic peri toneal lavage (DPL) was in 1965, 
and represented a major advance in the asse sment of abdominal injury. 
The study was small , but it was able to diagnose hemoperitoneum in 
I 00% of pati ents that presented with blunt abdominal trauma .S ince 
thi s initial in vesti gation, many studies have supported the result , and 
there has been a gradual increase in the use of DPL at trauma centres a 
a replacement for the non-therapeutic laparotomy. One such tudy by 
Danne et. al. in 1988 found that onl y 0.25% o f patients were not cor-
rectl y di agnosed within 4 hours of arri va l to the trauma centre, and fa lse 
negati ve and positi ve rates were similarly very low. Few complicati on 
o f the procedure were reported.9 
The primary fun cti on of DPL is to detect occult injuri es in hemody-
nami ca lly unstable pati ents that have sustained either blunt or penetrat-
ing abdominal trauma, even with a low thresho ld of suspic ion. A second-
ary fu nction a lso developed, namely, to save unnecessary laparotomies. 10 
The pri nciple of DLP is to infuse fluid into the peritoneum to mix with 
possible intraperitoneal blood, and to recover the fluid through drainage. 
A mall , midl ine inc ision is made in the sub-inguinal region and the 
linea a lba is separated. A peritoneal dia lysis catheter is inserted into the 
peritoneum and he ld in place by a purse string suture. Warm saline solu-
tion (0 .9%) i then infu ed, drai ned and ent fo r ana lysis. Depending on 
the ex perience of the phy ician , the entire procedure can take between 
5 to 30 min utes . However, there are orne ignificant limitations to the 
DPL.9 The procedure i invasive, it provides no information regarding 
the organ that is injured it has a high rate of negative laparotomies, and 
it can be time con uming if the operator is unskilled. Therefore, newer 
ultrasound-guided techni ques have largely ecl ip ed the DPL. 
FOC SED ASSE SMENT WITH ONOGRAPHY FOR TRAU-
MA 
e ment for trauma patient became popular in 
the early 1990 , addre ing the hort omings of DPL. The technique 
called Focu ed A e ment with onography for Trauma (FAST) was 
found very early to be accurate, non-inva ive, and could provide ex-
pedient a id in the decision-maki ng process for furth er treatment in the 
crit ica l care etti ng. FA T i a bed ide ultra ound a essment protocol 
that can be performed rapid ly a a creening tool fo r the detection of 
intraperi toneal injury and, le commonly, pericard ia! tamponade." The 
a essment i not overly complex, and can be performed by urgeons 
and radio logi t with equal re liab ili ty. 12 Currently, FAST is most often 
u ed by urgeons and phy ician in the emergency department. Canadi-
an ER practitioner ca ll the techn ique mergency Department Targeted 
Ultra ound ( DTU).13 
F T is perfo m1ed w ith the patient supine (if possible) and uses a 
mobile ultra ound machine. The depth of ultrasound wave penetration 
must be at lea t 20cm, so the tran ducer frequency that is usually re-
quired is 3.5-5MH z w ith a convex transducer. Several views are ob-
tai ned of hi gh ri sk areas of the abdomen prone to fluid accumulation 
after abdominal trauma. A longitudina l view of the right upper quadrant 
wil l allow vi ualization of the hepatorena l reces (Mori son 's pouch) that 
can show free fluid after a li ver laceration . A longitudinal view of the left 
upper quadrant to visuali ze the peri plenic pace will a ess for splenic 
and renal injuries. Both transver e and longitudinal iews of the supra-
pubic region (pouch o f Douglas) are u ed to ru le out urinary bladder 
rupture. Fina ll y, a Iran ver e view of the subxiphoid region is ometimes 
obta ined to as ess for free fluid of the pericardium." When perfom1ed 
by experienced sonographers, the entire exam wi ll take no longer than 5 
minutes to complete. However, complication in obta ining the standard 
v1ews can pro long the a sessment. 11 
FAST i currentl y indicated to be used in the primary circulatory 
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survey of an unstable patient that has sustained blunt abdomina l trauma 
for detection of intraperitoneal and pericardia! fluid. A secondary indi-
cation of FAST is the assessment ofthe thoracic cavity to detect a pos-
sible pneumothorax. This protocol , termed extended FAST (E-FAST; or 
EDTU-2 in the Canadian ER), is performed on unstable trauma patients 
if there is time after the primary survey. This exam is based on the prin-
ciple that air in the pleural cavity can be distinguished from air in the 
lungs with ultrasound during normal ventilation. E-FAST has reported 
sensitivities and specificities of 0.59-1.00 and 0.94-1.00, respectively.11 
It is currently unclear whether an E-FAST should be routinely conducted 
in the critical care setting, but it is reasonable to conclude that if there is 
sufficient time, an E-FAST can be performed to rule out pneumothoraces 
before patients go to the CT suite or surgery. 
ADVANTAGES AND LIMITATIONS OF FAST 
The FAST protocol has many key advantages that make it superior to 
DPL in the assessment of abdominal trauma. FAST boasts relative ease 
of use, rapidity, availability, and low cost imaging. It offer greater flex-
ibility for patient positioning, which is very important for patients who 
have undergone significant trauma. It can be employed within minutes 
of a patient's arrival at a critical care centre, while other health care per-
sonnel perform diagnostic and therapeutic maneuvers simultaneously.14 
A 2007 study found that patients with positive FAST results had sig-
nificantly higher mortality than FAST-negative patients. FAST-positive 
patients also had a higher likelihood of operation than FAST-negative 
patients. Patients with equivocal FAST results, or areas that cou ld not be 
well visualized, were found to have more statistically significant nega-
tive results and had a higher likelihood of operation than FAST-negative 
patients .14 However, equivocal results only made up 6.7% of the assess-
ments when FAST was undertaken by trained clinical sonographers.15 
These results highlight the importance of FAST as an effective method 
for identifying patients at risk of serious intraabdominal injury. FAST 
results can be used to guide mobilization of hospital resources, and iden-
tify patients who can be managed expectantly.14 
However, limitations to the FAST technique do exist. Firstly, FAST 
does not accurately detect the extent of, in some cases, the precise site 
of organ injury. Therefore, FAST-positive patients often need to be fol-
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lowed up with aCT scan to locate the origin of the bleeding and evalu-
ate the extent of the injury.16 The sensitivity of FAST is also low (34-
55%) relative to other imaging modalities available.17 Other limitations 
of FAST are aspects that are inherent to ultrasound itself as an imaging 
modality, such as operator dependence, inability to completely standard-
ize the procedure, limited retroperitoneal accuracy, and poor scanning 
results in obese patients or patients with tissue abnormalities like super-
ficial wounds.11 
DEBATE ABOUT THE CURRENT ROLE OF FAST 
There is considerable debate about what should be done in the case of 
negative FAST results for hemoperitoneum . Some studies show as many 
as 29% of negative scans still have some degree of intraabdominal in-
jury.18 Since CT scanning has become more widely available, faster, and 
a more economical test than it was in the past, it has come to dominate 
much of the survey of abdominal trauma patients. CT is a more accurate 
test than FAST, especially when comparing the false negative rates of 
both tests. The discordance in the results of CT and FAST have Jed to 
some centres adopting the CT scan as the primary imaging modality for 
blunt abdominal trauma.18 However, the utility of FAST is only ques-
tionable when it is used as a purely diagnostic tool. Recent evidence 
suggests that clinical suspicion shou ld sti ll play an important role in de-
termining the therapeutic steps for trauma patients. For example, if a pa-
tient sustained a seatbelt injury, a negative FAST result cou ld probably 
still be followed with aCT scan to ensure that no intraabdominal injury 
exists .19·20 A stand-alone FAST result shou ld not preclude patients from 
further investigation, or guide treatment by itself. It is in this setting that 
the value of FAST is realized. As a screening tool implemented in the 
primary circulatory survey, along with avai lab le clinical evidence, FAST 
is instrumental in the first decision point for trauma patients: to the OR 
or further investigation?14 Figure I depicts a typical decision tree, where 
FAST is integral to the early steps. In this role, FAST-positive patients 
can be dealt with in the most expedited manner possible, and patients 
with negative or equivoca l results can undergo further testing. This ap-
proach still results in effectively identifying the maximum number of 
at-risk patients, while using CT scanning sparingly. This saves the hos-
pital money, frees up valuable CT suite time, and avoids unnecessary 
radiation exposure to patients. Overall , FAST can be viewed not as a 
Intervention 
Yes 
No 
Observation 
CT Scan (follow CT path) 
Observation 
Figure 1. The typical decision-making process involved in the assessment of blunt abdomina l injury. Adapted from van der Viles et. aJ.2' 
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solitary solution to a diagnostic problem, but as an adj unct to the tri-
age and decision-making process. In this capacity, there will still be a 
very integral role for FAST in the work-up of blunt abdominal trauma 
patients for the foreseeable future. 
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INTRODUCTION 
For the past 40 years, the use of biomarkers has been extremely valuable 
in the early diagnosis of acute myocardial infarctions (AMI). Sens itiv-
ity, specificity and the clinical utility have continued to increase and 
current research suggests that this trend will continue. This article wi ll 
review the use of previous and current AMI markers and will conclude 
with a review of promising new markers. 
AMI BIOMARKER PROTOCOL 
To detect MI markers, venous blood is routinely drawn from patients 
with chest pain who are suspected of having symptoms of acute coro-
nary syndrome (ACS). 1 The marker of interest is presumed to be re-
leased from the cardiac tissue which is under ischemic stress and thus 
may be detected in the blood sample.2 A detected elevation in a particu-
lar marker may lead to early diagnosis and treatment and thus improved 
patient outcomes. 1 
Characteristics of biomarkers centre around three main elements, 
namely, kinetics of release, specificity and sensitivity.3 An ideal marker 
of cardiac necrosis should exhibit the following characteristics: cardiac 
specificity, early and stable release after necrosis, predictable clearance, 
and be measurable quantitatively using rapid, cost effective methodo lo-
gies available in the majority of clinical laboratories.4 
PAST AND PRESENT AMI BIOMARKERS 
Myoglobin 
Myoglobin is a heme protein found in almost all muscle types and is 
especially high in cardiac and skeletal muscle.5 Quantitative immunoas-
says are currently available. This marker 's strength is its high and early 
sensitivity post-MI. The marker 's obvious weakness is the low specific-
ity due to the presence of high levels of myoglobin in skeleta l muscle .5 
Therefore, myoglobin is suggested not to be used on its own but on ly in 
the context of other markers, EKGs and clinical evaluation . 
Lactate Dehydrogenase 
Lactate Dehydrogenase (LD) is an enzyme involved in anaerobic me-
tabolism, reversibly converting pyruvate to lactate.6 LD is fairly ubiqui-
tous; however, one of the five isoenzymes, LD I, is highest in cardiac tis-
sue. LDI is elevated post-MI and the LDI :LD2 ratio when greater than 
1.0 is diagnostic of an AMI. LD I elevation and LD I :LD2 ratio changes 
are detectable 8-12 hours post Ml and peak at 24-72 hours.7 
Creatine Kinase 
Creatine Kinase (CK) is an enzyme found in high amounts in muscle 
tissue due to its role in muscle contraction .8 CK has two subunits, M 
and B, which are combined to form three isoenzymes: CK-BB (CK-1 ), 
CK-MB (CK-2) and CK-MM (CK-3). 8 CK-MB is specific to cardiac 
tissue while CK-BB is found in brain tissue and CK-MM is in skeletal 
and cardiac tissue.8 Furthermore, release of CK-MB only occurs upon 
death of myocardial cells and it is not released in the setting of isch-
emia .9 Therefore, CK-MB was considered to be the most useful bio-
marker for detecting myocardial injury. Kinetic studies have shown that 
CK-MB is detectable 4-8 hours after the first onset of chest pain and 
peaks at 18-24 hours post MI.8· 9 However, the CK-MB Immunoassay 
lacks absolute specificity, is absent in minor myocardial infarctions, and 
has poor prognostic value in ACS patients. Despite these weaknesses it 
is currently a routine part of the cardiac work-up. 
In the 1970s and 1980s, CK-MB transformed the diagnosis and treat-
ment of patients with acute cardiac events. CK-MB proved even more 
specific than an accurate clinica l history, which is often unattainable in 
the critically ill or is atypical in the elderly and diabetics. CK-MB was 
more reliable than EKG pattern recognition which can be blind to dis-
ease depending on the location of the ischemia. CK-MB also improved 
specificity over myoglobin (90% vs 70% specificity, respectively) and 
consequently became the gold standard for identification of cardiac inju-
ry. In the absence of myocardial infarction, CK-MB may be elevated due 
to poor specificity in patients who present with multiple co-morbidities 
or conditions including renal failure, non-cardiac surgery, chest trauma, 
asthma, pulmonary embo li sm, chronic and acute muscle disease, bead 
trauma, hyperventi lation, and hypothyroidism.10• 11 
Troponin 
While troponin proteins are present in both cardiac and skeletal mus-
cle, the cardiac isoforms of troponin T and I are highly specific to the 
myocardium. Assays using specific antibodies against cardiac troponin 
Tor I allow measurement oftroponin release from the myocardium.4 In 
2000, the European Society of Cardiology (ESC) and American Col-
lege of Cardiology (ACC) task force concluded that diagnosis of AMI 
required biochemical evidence of necrosis and indicated the marker of 
choice as troponin .12 
The increased sensitivity of cardiac troponin over CK-MB is primar-
ily due to the fact that the percentage oftroponin released into the blood 
after an acute cardiac event is greater for troponin than CK-MB. Tropo-
nin concentrations rise quickly after the onset of chest discomfort. Thus, 
in upwards of80% of patients, a definitive diagnosis can be made within 
6 hours from the onset of chest pain . Furthermore, peak concentration 
of CK and troponin give a reasonable estimate of infarct size. More re-
cently, novel prototype cardiac troponin assays have been developed 
that are up to 1 0-fold more sensitive than the currently used assay and 
yie ld prognostic value on potentia l future Mls. 13· 14 For comparison of 
troponin and other available markers please see Table I. 
Troponin has become the biochemical marker of choice for the de-
tection of cardiac injury. But still lacks sensitivity within the first hour 
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LD IILD2 rati o 
N/A 
Troponin cTnl, cTnT <0.08 ug!L 
of an AM 1. 15 Furthermore, clinical guide lines still dictate that Troponin 
results should be interpreted wi th clinica l findings and EKG results and 
not in isolation.16 
FUTURE MARKERS 
While current markers have greatl y improved the diagnosi and qui ck-
ened the treatment of AMI patients, there is still room for improvement, 
especia lly in the area of early detection.3 The fo llowing markers are 
some of the potential MI markers of tomorrow that may improve sen-
iti vity, specificity, prognostication and decrease time between (or even 
predict) chest pain onset and diagnosi /treatment. 
Myeloperoxidase 
Myeloperox ida e (MPO) is a haemoprote in produced by polymor-
phonuclear neutropbils (PMN) and macrophages. It converts chloride 
and hydrogen perox ide to hypochlorite which i re lea ed during infl am-
mati on and is in volved in lipid oxidation that is conta ined in LDL par-
ticles. This process promotes fo rmation of foa m cell in atherosclero-
sis. MPO is a marker of plaque instabili ty and therefore presents a a 
potentia l strong prognostic marker of an MI in the near future. MPO i 
lowest in patients wi th stable coronary artery disease, hi gher in patients 
with unstable angina, and highest in patients with AMI. 17 
Copeptin 
Copeptin is the C-terminal fragment of the vasopressin precursor 
hormone whi ch i released in response to low blood pressure. Also, the 
measurement of copeptin has been shown to have very strong negati ve 
predicti ve value, along with troponin , fo r AMI. 18 Additi onally, copeptin 
levels are elevated early after AM I and are detectable in patient who 
present soon after symptom on et whil e troponin is st ill negati ve.19 
Growth differentiation factor 15 
Growth di fferentiati on fac tor 15 (G DF- 15) i a transform ing growth 
factor. Cardiomyocytes ex press and ecrete GDF- 15 in the setting of 
ischemia and reperfusion, suggesti ng that it might be a protective fac-
tor. As well , GDF- 15 bas been ident ified in acti vated macrophage , and 
a di stinct up-regu lation has been found in many tis ue fo llowing inj ury, 
ischemia, and other forms of stress.20 
Heart-type fa tty acid-binding protein (H-FA BP) 
H-FAB main advantage is that it is re lea ed soon after cardiac in-
j ury and thus may be a great potentia l improvement fro m myog lobin 
as an early biomarker. The main di advantage i that it is not exc lu ive 
to heart (a lso is found in skeleta l muscle - although in much smaller 
amounts).21 Add iti onall y, it is useful in di stinguishing ri sk even in pa-
tients without elevated BNP or Troponin .22 
8 -type natriuretic peptide (BNP) and N- Terminal fragm ent of pro-BNP 
(NT-proBNP) 
BNP i a neurohormone re leased from cardiac cell s fo llowing ver-
tica l wa ll stress and myocyte stretching. 22 Both the active form BNP, 
and the inactivated N-Term inal peptide "NT-proBN P" can be mea-
8-1 2h 90%190-99% 
2-4h I0- 12h 99%170% 
2-8h 18-24h 99%/99% 
sured as markers o f hemodynamic stress). Whil e investigations have 
shown that e levated BNP and NTproBNP levels are predictive of death 
and heart fai lure they are not use fu l as indicators of new or recurrent 
AMJ.23.24 More research is bei ng conducted to establish the use of these 
biomarkers for selecting treatment of acute coronary syndromes.22 
high sensitivity C-reactive protein (hsCRP) 
C-reactive prote in is a marker of inflammation and may be part of 
the mechani sm of atherosclerotic plaque producing thrombus. Elevated 
leve ls are predicti ve of death and heart fa ilure post MI. hsCRP is non-
specific fo r cardiac inflammation; however, measurements of forms spe-
cific to vascular inflammation are being developed and may be more 
pecifi c fo r AMl 25 
placental growth factor (PIGF) 
PIGF is also a useful indicator of plaque instabili ty - more specifi-
ca lly - may be a determ inant/cause of plaque instabili ty and thus is a 
potential drug target to prevent AMJ.26 
WBCHO and p lasma choline (PLCHO) 
Whole blood choline (WBCHO) incl ude measurement of choline in 
hemolysed erythrocytes. Choline leaks from ischemic tissues into plas-
ma. In pia rna, it is eventually taken up by blood cell (hence the di ffe r-
entiati on between these two measurements). Both whole blood choline 
and plasma choline level are of u e fo r predicting cardiac ischemia in 
patient with negative troponin. The use of whole blood choline may 
also extend to determ ining plaque stabili ty. Thus, the e markers might 
be of u e fo r predi cting myocardi al infarct (detection pre-necro is)Y 
CONCLUSIONS 
Over the past several decades, the use of cardiac biomarkers has 
greatly improved the diagno is of AMI . As more markers have 
emerged, en itiv ity and pecificty has increased and time to diagno-
i and treatment ha decrea ed. Currently, the be t marker avail-
able in clinical practice i troponin ; however even troponin results 
hould be interpreted within a clinica l context and not used in iso la-
tion. Furthermore, there i still room for improvement and cur-
rent research seem to suggest there are more marker sti ll to come 
whi ch w ill improve AM I diagno tics, prognostics and prediction . 
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J, a 36 year old mother of two is brought into the emergency de-partment by police fo llowing her neighbours' complaints of violent threats made by her towards them. J bas a history of manic depres-
sive episodes but has never acted violently or displayed homicidal ide-
ation. The attending emergency physician examines 1 and notes that she 
bas recently demonstrated recurrent episodes of unexplained aggression 
towards family members. The physician is concerned that this presenta-
tion represents a worsening of J's psychiatric illness, and that she could 
present a risk to herself, her family or her neighbours. 
The application for psychiatric assessment (APA), also known as a 
Form I in Ontario, is a widely used tool available to phys icians who 
have a "reasonable cause" to believe a person should be mandated to 
undergo a psychiatric evaluation in an in-patient setting. Here we review 
the circumstances under which a Form I can be applied, highl ighting the 
legal basis and focusing on its use in the emergency department. We also 
outline the patient 's rights when a Form I is applied to them, as well as 
the consequences for the patient and the responsibili ty of the signing 
physician as out lined under sections 15, 18 and 20 of the Ontario Mental 
Health Act. ' In addition, we will discuss some of the ethical and legal 
implications of Form I use. 
THE LEGAL BASIS OF FORM 1 USE 
A Form I can be applied when a licensed physician believes that the 
patient has either threatened or attempted harm towards themselves or 
others through action or neglect due to psychi atric causes . Note that fo r 
non-psychi atri c medica l causes, such as brain injury re ulting in cogni-
ti ve impairment, a patient can be detained without a Form I. Although 
the signing physician must personally examine the patient within seven 
days prior to a Form I being signed, any phys ician can perform the sa id 
exam under secti ons 15.1 and 15.2 of the Ontari o Mental Hea lth Act 
(OMHA). A poli ce offi cer who has suspicions similar to those outlined 
above may take a person into custody under section 16 of the OMHA, 
but must fac il itate an eva luation by a phys ician as soon as rea onably 
possible, and the physician may then fi ll a Form I. In the event that the 
patient is in the communi ty when a Form I is signed, deli very of the 
patient to a fac il ity with psychi atric in-pati ent serv ice (also known a 
a schedu le I fac ility) can be fac ilitated by anyone, citi zen or law en-
forcement official, within the seven day expiration peri od. In London, 
schedule I facili ties include: Victori a Hospi ta l, Un iversity Hospital, St 
Joseph 's Hea lth Care and Regional Mental Health Care - St Joseph 's.2 
FORM I USE AND ITS OUTCOMES 
On a Fonn I, the physician must outline the findin gs that have contrib-
uted to suspicion of a mental disorder, including fac ts that were reported 
by collatera l sources such as the police or fa mily members (section 
15.3). 1 Upon the completi on of a Form I, the pati ent can be held without 
consent in hospital fo r up to 72 hours in order to fac ilitate a complete 
evaluation (section 15.4). On a Form I , the physician must select either 
"Box A - Serious Harm Test" or "Box B - Patients Who are Incapable of 
Consenting to Treatment and Meet Specified Criteria".3 Box A focuses 
on past, present and future ri sks or threats of harm to themselves or 
others. If Box A is used, the patient can be held for exam as described 
above, but treatment cannot be provided without consent. Box B on the 
other hand is used for pat ients who meet the foll owing criteria: I) they 
have an establ ished mental diagnosis that has improved with treatment, 
2) without treatment they are incapable of consenting to treatment (rec-
ognizing that wi th treatment they may or may not be incapable of con-
senting to the treatment), and 3) they pose a risk to themselves or others. 
By completing Box B, the physician affirms that under the Health Care 
Consent Act, the patient is incapable of consenting to treatment and a 
substitute decision-maker will be consulted (in relation to the relevant 
psychiatric treatment). It is worth noting that due to the fact that Box B 
requires considerable background knowledge about the patient, its use in 
the emergency department is rare. The vast majori ty of Form I applica-
tions by non-psychiatric physicians are made using "Box A". 
In addi tion to a Form I, the physician must also complete and pro-
vide the patient with a Form 42, which is a noti ce to APA, meant to 
inform the patient that be or she is being held in hospital and the reasons 
for this decision. A Form 42 outlines the patient's right to contact a law-
yer without delay and the responsibili ty of the hospital to aid that con-
tact. The Act does not mandate that the physician read the patient their 
ri ghts or noti fy a rights advisor about the involuntary detainment under 
a Form I (a rights advisor is legally required to be notified by the physi-
cian for in lances of involuntary admission as with a Form 3 and a Form 
4 per the OMHA). However, the phys ician should inform the patient of 
the current therapeutic plan and that the patient will remain in hospital 
unti l a p ychiatric assessment can take place by a certified p ychiatrist. 
In contra t to an invo luntary admission decision under section 20 of the 
OMHA, a patient on a Form I does not have the right to appeal a Form 
I decision to the Consent and Capacity Board. 
Following the 72 hour evaluation period, there are three possible out-
comes to Form I use: the patient can be released, the patient can be ad-
mitted voluntarily under section 12 of the OMHA, or the patient can be 
invo luntari ly admi tted to a schedu le I fac ility following the completion 
of a Form 3 by a physician under ection 20. 1.1 of the OMHA. 1 Note 
that if a decision is made to invo luntarily admit, the admitting physician 
cannot be the same one who completed the Fonn 1.4 
FORM I USE AND MEDI CO-LEGAL CONSIDERATIONS 
We found n? precedent of a physician having successfu l legal action 
brought agamst them for the use of a Form I . This may be due to the 
fac t that patients cannot appeal the app lication of a Fonn 1 and that the 
short duration of a Form I can be considered to result in ~nly a minor 
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Form 1: Application for Psychiatric Assessment (ASA) 
Completed when a physician believes that due to a mental 
health condition, a patient: 
• Has attempted harm to others or themselves 
• Has threatened harm to others or themselves 
• Is unable to care for themselves 
Rights of the patient: 
• To be immediately given a Form 42 outlining the 
reasons for being held in hospital 
• To be assessed for a period of no more than 72 
hours, during which they receive a formal psychiatric 
evaluation 
• To contact a lawyer without delay 
Responsibility of the physician and hospital: 
• Facilitate the patient's rights outlined above. 
• To not provide treatment without informed consent 
under Box A. 
• Explain the patient's rights and situation. 
Results of a Form 1 after no more than 72 hours: 
• Patient is released back into community 
• Patient is admitted voluntarily 
• Patient is admitted involuntarily upon completion of a 
Form 3 
A Form 1 expires 7 days after being signed. A physician 
can only sign a Form 1 if they have personally examined 
the patient. 
A Form 1 can be found at: http://www.health.gov.on.ca/en/ 
public/forms/mental_fm.aspx 
Figure 1: Quick guide to Form I 
restriction of freedom and hence of minor legal importance. Referring 
to limiting physicians' liability in cases of involuntary detainment of 
longer duration, the Canadian Medical Protective Association recom-
mends that physicians continue to exercise their judgement and opinion 
honestly and in the best interest of the patient and others. 5 This recom-
mendation could be applied equally well to the application of the Form 
I, even ifthere is no legal precedent of actual liability in these cases. 
THE INVOLUNTARY PATIENT 
In the event that there is reasonable cause to suspect that a patient may 
cause harm to themselves or others in the near future, such as in J's case, 
an ER physician will likely wish for the patient to undergo a psychiatric 
assessment (PA). Importantly, this may occur voluntarily or involun-
tarily if the physician deems it necessary. A Form I is only required for 
involuntary detainment of a patient. 
In order to be an acceptable voluntary candidate, the physician must 
be reasonably confident that the patient will comply with instructions 
and is unlikely to cause harm. This assessment includes the consider-
ation of several factors, such as suicide, harm to others, self-harm and 
self-care. Further, the severity and intensity of ri sk-related thoughts, for-
mulation of dangerous plans, access to lethal means, level and compe-
tency of supervision and willingness to contract for safety (an agreement 
the patient makes to seek help before acting on self-harm or aggressive 
impulses) are important factors to consider. In addition, the patient's 
support system is an important factor and the absence or withdrawal 
of this support may be a deciding factor for the patient's involuntary 
detainment.6 lt is important to note that meeting the above criteria hinges 
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on the experience and comfort level of the physician with identifying 
risk factors and dealing with high risk psychiatric situations. 
Hence, to use a Form I, the patient must not be an appropriate vol-
untary candidate. This is decided on the basis of weighing the complex 
interplay of social, psychological and medical variables in the patient 's 
life. To some degree this assessment may be influenced by the ER physi-
cian's experience and the practical demands of running a busy ER de-
partment. 
GROUNDS FOR PATIENT DETAINMENT 
The decision to involuntarily detain a patient balances the restriction of 
a patient 's liberty and the need to safeguard the patient and/or society. 
This may result in stigma or emotional trauma to the patient from the 
restriction of freedom . This is a significant social and moral matter, con-
sidering there are only a handfu l of circumstances in which our society 
permits such restrictions against an individual , such as during criminal 
proceedings. 
The implied rationale for detainment is that the short-term cost to the 
individual is acceptable to society at large to help prevent future harm. 
This is a significant matter considering that a patient may be detained 
even if they have not performed any harmful actions, such as in J's case. 
The patient may merely be suspected with reasonable cau e by the phy-
sician to be likely to carry out harmful actions in the near future. Indeed, 
the criteria for Form I use are broad and non-specific, and can be applied 
to many patients, sometimes even in situations where the necessity of 
the use of a Form I is debatable. This large amount of power given to 
physicians in the legislation can serve the patient and society well if ap-
plied judiciously. Conversely, if it is applied in a less than conscientious 
manner, there is potential for abuse or negligence. 
Additionally, there are inequalities relating to the time frame of the Form 
I . For example, in a major urban centre where psychiatric care is readily 
available, the patient will often receive a psychiatric assessment within 
several hours of medical clearance and will not have to be admitted into 
hospital. However, in underserviced regions, access to a psychiatric as-
sessment may be difficult and the patient may be admitted to a non-
psychiatric facility (a non-schedule I facility) while he or she awaits a 
psychiatric assessment.6 In fact , under the law there is no limitation to 
the repeated use of Form I to detain patients for longer than 72 hours. 
In the above-noted case, J was detained under a Form I and was re-
leased following a psychiatric assessment and the completion of a treat-
ment plan. Still , in some cases, patients who are detained involuntarily 
incur an individual cost, in spite of the legally-based assumption that 
this will protect society or themselves. The decision to utilize a Form 
I should not come lightly and must adhere to all the requirements out-
lined here. A Form I entrusts physicians with significant powers based 
on the legislature's trust that they will abide by stringent principles in the 
decision-making process. 
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ACUTE CORONARY SYNDROME 
Acute Coronary Syndrome (ACS) is a general term used to describe a 
spectrum of life-threatening conditions affecting the heart and circula-
tion. In ACS the heart 's blood supply becomes suddenly restricted by 
the formation of a thrombus in the coronary arteries. Depending on the 
severity of the blood clot, a spectrum of heart conditions can occur. This 
spectrum ranges from minor chest pain (angina) to major cardiac events 
including myocardial infarctions.' 
A number of risk factors are associated with the development of 
ACS. These include smoking, obesity, hypertension, diabetes, dyslipid-
emia and aging. As the prevalence of these risk factors increase within 
Canadian society, the societal cost of ACS continues to increase.' 
DIRECT MEDICAL COSTS OF ACS 
Affecting approximately I 00,000 Canadians each year, ACS is currently 
the second leading cause of death in Canada. In 2008-2009, there were 
109,109 hospitalizations due to ACS and over 21 ,000 deaths.' Although 
a large proportion of deaths from ACS occur before the patient reaches 
the hospital, emergency rooms are the primary sources of treatment for 
Canadians presenting with ACS.2 
A combination of numerous factors, including severity of the ACS 
event, hospital resources, and local clinical practice determine the total 
direct medical cost of ACS . With these variances in mind, the national 
average hospitalization cost for a heart attack in 2008-2009 was found 
to be approximately I 0,000 dollars and the national average for treating 
acute chest pain was approximately 4,500 dollars. Representing a total 
annual direct cost of over 1.5 million dollars each year, ACS is clearly a 
large burden on Canada's finite medical resources. ' 
ECONOMIC COSTS 
In addition to the direct medical costs outlined above, ACS al so repre-
sents a significant burden on Canada 's economy. Productivity losses 
in the form of premature retirement, increased sick leave and death of 
qualified workers all contribute to a decrease in national Gross Domestic 
Product. ACS is responsible for 1.3 days of sick leave per year con-
tributing a cost of 1.8 billion to the Canadian economy in 2008-2009.' 
Representing approximately 0.12% of the 2009 gross domestic product 
of Canada this economic cost is clearly placing a significant burden on 
Canada's economy.' 
CURRENT TREATMENTSTR UCTURES 
Depending on the severity of a patient's presentation, numerous diag-
nostic and medical procedures are performed in hospital to treat each 
patient presenting with ACS. ACS is currently treated using procedures, 
lab tests, risk stratification and recommendations about lifestyle chang-
es depending on each patient's presentation. Different centers across 
Canada have unique procedures for ACS triage and treatment.3 The in-
dividualized method common to most emergency rooms has however 
been fo und to be only 73 .8% sensitive for detecting cases of ACS. In 
fact, Christenson et al. found that the average Canadian emergency room 
misses 5.3% of ACS cases and that considerable heath care resources 
are expended on inefficient diagnostic and treatment procedures.3 This 
article discusses the medical and economic benefits of a new form of 
ACS triage - Chest Pain Units . 
CHEST PAIN UNITS (CPU) 
Numerous methods have been developed over the years in response 
to the unsatisfactory diagnostic quality of Acute Coronary Syndrome 
(ACS) identification in emergency departments. The chest pain evalua-
tion unit, or chest pain unit (CPU), is an area within the hospital or the 
emergency department itself that is used to reduce inadvertent discharge 
of patients with low to moderate risk of ACS. While many different pro-
tocols are adopted across hospitals, CPUs try to identify acute myocar-
dial necrosis, rest ischemia, and exercise-induced ischemia4 
Within the CPU, patients are assessed using past history, risk factor 
identification, physical examination, serial ECGs and serial evaluation 
of cardiac biomarkers. Patients are usually kept in the unit for a mini-
mum of 6 hours and may be observed for as long as 18 hours, depending 
on the test results . Patients with positive test results for serial markers, 
such as the level of high sensitivity troponin, are admitted to the hospital 
for further evaluation .5 Those with a negative result may be referred for 
further testing, such as graded exercise testing, stress nuc lear imaging or 
stress echocard iography.4 
COST EFFECTIVENESS 
In the United Kingdom and United States, many studies have been done 
to examine the cost effectiveness of chest pain units. In these studies, 
costs included both direct and indirect medical costs, and the effect mea-
sured is the quality adjusted life year (QALY) gained.6• 7• 8 From an eco-
nomic viewpoint, a cost effective intervention should provide positive 
incremental value. Within this, interventions that provide an increased 
benefit at a lower cost are considered dominant and should be adopted; 
whi le an incrementa l cost effectiveness ratio (difference in costs/differ-
ence in effects) should be calculated for treatments that are more ex-
pensive. 
In the past decade, many single center studies were done in the USA 
that compared the use ofCPUs with hospital admission for patients with 
low to moderate risk of ACS. These studies all found the CPUs to be 
more cost effective than hospital admission. More recently, studies were 
done that compared the use ofCPUs with standard care based on the ex-
pertise of the emergency department staff. These studies are more likely 
to estimate real differences due to the fact that not all patients receiv-
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ing care become inpatients. In one single center study conducted in the 
UK, it was found that CPUs reduced the number of admissions to the 
hospital and improved health utility. 7 CPUs were also associated with 
an increased cost of2,750 pounds (or 4300 dollars) per QALY gained, 
but this was well within the value of 20,000-30,000 pounds per QALY 
recommended by the National Institute of Clinical Excellence. Overall, 
the study estimated a 95% probability that CPU will be cost effective.7 
Subsequent multicentre studies in the UK, however, were unable to 
reproduce the findings . The Effectiveness and Safety of Chest Pain As-
sessment to Prevent Emergency Admissions trial showed that CPU care 
did not reduce the number of patients admitted and may even increase 
admission from emergency and other routes.6 Another study investigat-
ed whether or not CPU care may be cost effective by improving health 
outcome and reducing cost in other ways. The study did not find any 
significant differences in health outcome between CPU care and routine 
care and only estimated a 70% probability of CPU being cost effective.6 
These studies are subject to many uncertainties and more research is 
recommended to a certain whether or not the immense capital required 
for implementing CPU care is justified. 
STATUS lN CANADA 
In contrast to USA, CPUs are not widely adopted in Canada, nor have 
there been studies comparing u e of a CPU with the current unstructured 
approach across hospitals. When compared with the United States, there 
is evidence suggesting that the current approach is unsatisfactory due 
to a higher than accepted rate of missed patients from early discharge3. 
In partial response to this, British Columbia has begun recommending 
patients with possible ACS be observed in the ED and undergo serial 
testing for cardiac biomarkers9. Nevertheless, add itional evidence is 
needed to convince administrators and clinicians across the country that 
CPU models can be cost effective. This is particularly difficult given 
the lack of common baseline performances between emergency depart-
ments in Canada. 
OTHER METHODS TO IMPROVE DIAGNOSIS 
Given that CPU itself is a response to the diagnostic uncertainty encoun-
tered in the ED, improvement of current diagnostic methods or strate-
gies in the ED is also a viable option in improving patient outcome. 
One method that has been studied is the use of point of care (POC) bio-
markers as opposed to serial testing in patient risk stratification. In one 
hospital in Thunder Bay, it was reported that the introduction of POC 
biomarkers helped to reduce ad!llission and saved costs. 10 In another 
multicentre trial , the use of POC assessment was linked to reductions in 
hospital admissions, but the associated cost was greatly increased such 
that the probability of it being cost effective was less than I 0%. This wa 
due to the increased use of cardiac interventions associated with POC 
biomarkers.11 Further research is needed to evaluate whether or not these 
increased interventions resu lt in addi tional patient benefits . 
Similar to POC testing, Cardiac Computed Tomography (CCT) has 
also been explored as an alternative to the current standard care. A single 
center US study done recently included both ED costs and downstream 
costs associated with CCT, and it found that CCT had a 99% probability 
of costing less than the standard of care testing12 • This was primarily due 
to the differences in cost between CCT and stress testing, particularly 
when stress nuclear imaging was used in the standard care. Although 
promising, there are limitations associated with the use of these imaging 
techniques, such as increased radiation exposure and decreased perfor-
mance in patients with high body mass index.13 In addition, there is great 
variability in diagnostic accuracy across centers with this technique, 
which needs to be addressed before uni versal adoption .14 
CONCLUSION 
Currently, there is no single optimal evaluation protocol across hospitals 
that can accommodate for the differences in local resources and exper-
tise. In addition, there is insufficient evidence to advocate for the formal 
implementation of chest pain units in Canada. Further research in this 
area is recommended in order to improve the outcome of patients with 
suspected ACS. 
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Breastfeeding promotion: the NICU perspective 
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B reastfeeding is recognized as the best source of nutrition for all infants, and the World Health Organization (WHO) recommends exclusive breastfeeding unt il 6 months of age.1 Breast milk pro-
vides protection against infection, autoi mmune disease, and gastrointes-
tinal dysfunction and promotes cognitive development. 2 The benefi cial 
effects of breast milk can be seen even more clearly in preterm and low 
birthweight infa nts being treated in the Neonatal Intensive Care Unit 
(Nl CU), where in fection and neonatal sepsis are more common. These 
babies wi ll also benefit from the ana lgesic properties of breastfeeding 
during medical procedures .1 However, studies have shown that breast-
feeding rates for low birthweight infants are lower than their normal 
birthweight counterparts. 3 
In order to promote breastfeeding in hospitals around the world, the 
WHO has developed the "Baby Friendly Hospital Initiative" (BFHI). 
This initiat ive provides ten steps that must be achieved before a hospi-
tal can be formally accredited with BFHI status. Many successes have 
been seen since the program's implementation, including an increase 
in breastfeeding initiation and duration, and a decrease in incidence of 
neonatal infection and atopic eczema.4 ln Canada, the rate of breastfeed-
ing at discharge is now at 80%, although exclusive breastfeeding rates 
remain low. 1 
BFHI has shown success in all hospital units, including the NICU. 
An Austra lian study showed that, 4 years after implementation, breast-
feeding initiation rates in the NlCU rose fro m 35% to 75% and exclu-
sivity at 2 weeks from 10% to 40%.2 However, there has been trouble 
implementing all ten steps in the unique NICU environment. For ex-
ample, the steps include allowing mothers and babies to room together 
and discouraging the use of artific ial pacifiers; these steps are often im-
possible in the NICU, where there are no individual rooms and pac ifiers 
are used to promote oral motor ski ll s in premature in fa nts.4 It has been 
suggested that the WHO develop a subset of BFHI steps specifica ll y for 
the NlCU to provide guideposts fo r hea lth workers and admini strators.5 
Breastfeedi ng promotion in the N ICU faces a un ique set of chal-
lenges. Because many of the in fants are premature, oral motor ski ll 
are often poorly developed and these in fants may display an inabi lity 
to latch and suck.5·6 Th is means that mothers must often use manual or 
electronic breast pumps to express mil k, which is then fed to the infant 
by gavage or oral feeds. The lack of d irect suckling, combined with the 
obvious stresses of havi ng a sick infa nt, cau e the mother 's milk suppl y 
to qu ickly decline.6 To achieve an adequate milk supply, mothers may 
have to pump for over 2 hours a day, which can itself be stressful and 
exhausting.2 As we ll , the lack of electronic breast pumps and privacy 
screens in the NICU can di scourage mothers from attempting to breast-
feed.5 
A 2007 study of factors influencing breastfeeding in the NICU fou nd 
that a lack of systemic, consistent advice prevented mothers from ini-
tiating and maintaining breastfeeds. Women reported that, while many 
NlCU nurses were knowledgeable, they had never di scussed breastfeed-
ing with thei r obstetrician or neonatologist. 3 This was echoed in another 
study, in which mothers reported that they received great help from 
lactation consultants, but did not fee l that physicians were supportive.7 
Many NICU staff still promote formu la feeding, and formula companies 
still sponsor many of the educati onal lectures on neonatal care.5 
Another barrier to breast feeding is the design of NlCUs, which do 
not promote alone time or skin-to-skin contact between mothers and in-
fants. A recent study found that only 16% of infants in the NICU were 
held skin-to-skin with their mothers, a practice which has been shown to 
increase breast milk quanti ty.3 Because the NlCU is more medicalized 
than other maternity wards, the focus seems to be on breast milk as a 
product instead of breastfeeding as a natural process benefi cial to both 
mother and infant. 7 
Several strategies have been employed to try to counter the inherent 
challenges of breastfeeding in the NICU . In response to mothers ' com-
plaints that thei r attempts at breastfeeding were being undermined by 
the negative attitudes of and inconsistent advice from NICU staff, one 
hospital implemented an educati onal intervention designed to improve 
the breastfeeding knowledge of NICU nurses.8 After the 8-hour educa-
ti onal session, which covered breastfeeding theory and techniques, an 
analysis of pre- and post-intervention questionnaires revealed a signifi-
cant increase in breastfeeding knowledge compared to control nurses 
fro m other wards who did not attend the education session.8 The authors 
suspected that the increased number of mothers providing breast milk 
fo r their infants at the time of discharge from the NlCU during the year 
following the intervention was related to the nurses ' improved koowl-
edge.8 A series of foc us groups with NICU nurses in Australia revealed 
the perspecti ve that staff education was also the key to improving the 
confidence of nursing staff so that they could fee l more comfortable pro-
moting breastfeeding to both mothers and other colleagues, including 
doctors.5 
In some settings, mothers of NICU infants may benefit from addi-
ti onal support beyond what is prov ided by staff; one study fo und that 
hav ing access to a peer counselor (a woman fro m the loca l communi ty 
with breastfeedi ng experience who had attended a 5-day breastfeeding 
course) led to 18 1% greater odds ofbreastfeeding at 12 weeks compared 
to mothers who only received the standard of care (P=.03) .9 Peer coun-
selors provided verbal advice or phys ically helped the mothers to breast-
feed, pump, and engage in skin-to-skin holding over a 6-week peri od.9 
One hospital in West Virginia took the opportuni ty to evaluate the 
impact on breastfeeding rates when it re-designed its N ICU from a more 
traditional open-bay ward with mul tiple neonates in a large room to a 
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single family room (SFR) unit with a private room for each neonate. 
After the re-design, 20% more infants were discharged from the NlCU 
breastfeeding, and infants in the SFR received maternal breast milk on 
90% of days spent in the NlCU compared to 66% of days for neonates 
who stayed in the open-bay ward.10 This improvement may have been 
owed to the more private, tranquil environment of the SFR unit, which 
should have enabled mothers to spend more time with their infants and 
engage in more skin-to-skin contact. 10 
Whenever new hospitals are built or NlCUs are renovated, designers 
should attempt to maximize privacy and comfort for mother-infant pairs 
to promote breastfeeding, pumping, and skin-to-skin contact. However, 
limited visiting hours and having to travel large distances between home 
and the hospital many continue to present significant challenges for 
mothers in some settings.11 Hospitals should ensure that all mothers with 
an infant in the NlCU have access to a high quality electric breast pump 
at home to maintain lactation when the mother and infant are separated.2 
Despite the many barriers to successful breastfeeding that are present 
in the NlCU, it is possible that the prolonged hospital stay may provide 
an important opportunity for enhanced maternal breastfeeding educa-
tion compared to other maternity wards where infants are discharged 
from the hospital soon after birth. 5 This opportunity can be augmented 
through the strategies discussed above, namely improved staff education 
and a peer counseling program. 
The NlCU at London Health Sciences Centre (LHSC) uses a variety 
of approaches to encourage mothers to breastfeed their infants.12 The 
majority of NlCU rooms have only two infant beds and curtains that 
can be drawn for further privacy. Mothers are able to breastfeed, pump, 
or engage in skin-to-skin contact in their infant's room, or can choose 
to go to a separate room where several electric breast pumps are avai l-
able . Visiting hours do not apply to mothers, who are able to stay with 
their neonates around the clock. Mothers are able to stay on the hospital 
grounds or in the NlCU itself, eliminating the burden of having to travel 
large distances between home and the hospital. However, some mothers 
with other children at home may not be able to spend as much time at 
LHSC. 
In addition to the support and advice that mothers receive from the 
NlCU's Lactation Consultant, they are provided with several pamphlets 
with breastfeeding and pumping instructions, as well as charts to record 
milk volume. These pamphlets and information sheets are avai lable in 
several languages, and interpreters are also available if necessary. Moth-
ers are encouraged to rent hospital-grade electric breast pumps, and a 
loan program exists for mothers who cannot afford to do so . In an effort 
to be as inclusive as possible, non-electric foot peddle-operated breast 
pumps are avai lable for Mennonite mothers who do not have electricity 
at home. 
While the LHSC NlCU discharges the vast majority of its neonates 
breastfeeding, it remains a challenge to get mothers to continue breast-
feeding once they return home. This year, the hospital will begin running 
a post-discharge nutrition clinic so that high-risk infants and their fami-
lies can return for further support. Despite its many successfu l practices, 
LHSC has not yet complied with all of the BFHI requirements. One ma-
jor barrier to this achievement is that infant formula companies are sti ll 
allowed to provide their product for free at LHSC (health care faci li ties 
must purchase formula to be BFHI-certified). 
The importance of breastfeeding for a ll infants, and NICU infants in 
particular, has been recognized around the world . The BFHl has provid-
ed hospitals with guidelines that can be used to promote breastfeeding 
to mothers and staff alike. Even though the NlCU poses certain chal-
lenges, creative solutions have been identified to increase breastfeed-
ing rates and duration in this environment. The u~e of electron.ic breast 
pumps, increased staff education, and single fam1ly room des1gn h~ve 
all been shown to increase the comfort and frequency of breastfeedmg 
in the NICU. Many of these solutions have already been used a LHSC, 
which has resulted in high rates of breastfeeding on discharge. Hope-
fully, widespread implementation of some of these solutions can help 
promote the use of breast milk in all hospital NICUs. 
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INTRODUCTION 
Interdisciplinary collaboration plays an important role in the provision 
of health care. This role is even more pronounced in intensive care set-
tings where nurses, physicians, and other health professionals work 
more closely together than other areas of the hospital. Numerous articles 
in the medical literature suggest that collaborative practice in intensive 
care units (ICUs) is essential to reduce patient morbidity/mortality and 
improve patient outcomes.1 Collaborative practice has the additional 
benefits of reducing health care costs and improves job satisfaction for 
the members of the interprofessional team.1 While the benefits of phy-
sician-nursing collaboration in the ICU are well described in the litera-
ture, there are gaps when translating these princip les to clinical practice. 
This article aims to describe current collaborative practices in the ICU 
and discusses the barriers and challenges associated with this practice 
model. Furthermore, we make recommendations geared towards medi-
cal students to improve collaborative practice in the ICU setting. 
The meaning of ' collaboration ' or ' collaborative practice ' is not 
clearly defined in critical care literature. Weiss & Davis model is com-
monly used, and describes collaborative practice as interactions between 
nurse and physician that enable the skills and knowledge of both pro-
fessionals to synergistically influence the patient care being provided.1•2 
That is to say, collaborative practice occurs when professionals work 
together to provide patient care. 
CURRENT COLLABORATIVE PRACTICE IN CRITICAL 
CARE SETTINGS 
Currently, collaborative practice and teamwork amongst interdisciplin-
ary teams relate primarily to sharing of responsibility. Little emphasis 
is placed upon coordinating decisions based on input from team mem-
bers.3 Consequently, team practices tend to occur in a parallel , multi-
disciplinary manner, instead of involving all team members in decision 
making as desired by interdisciplinary collaboration. Efforts to improve 
collaboration have sought to implement ' potentially better practices 
(PBPs)' , defined as evidence-based practices that have been shown to 
improve outcomes in one setting, and which can be selected, modified 
and applied in unique ways to fit a new situation.4 In one study, five cen-
tres were involved in a focus group studying neonatal ICU (NICU) envi-
ronmental design and its impact on the neurodevelopment of neonates. 5 
The group identified 16 PBPs using an evidence-based approach, includ-
ing tactile stimulation and developing a system for noise assessment of 
the NICU acoustic environment. Collaborative development and sharing 
of educational tools played a crucial role in successfully implementing 
these PBPs and involved multiple professions within the intensive care 
environment. 5 Moreover, the importance of interdepartmental collabora-
tion was identified when taking suggestions from multiple caregivers 
regarding noise sources in the neonates ' environment.5 
Furthermore, specific positive effects of interdisciplinary collabora-
tion interventions have been documented in intensive care settings.6 One 
study evaluated the effectiveness of collaborative decision-making pro-
cesses on the process of weaning from mechanical ventilation in a medi-
cal intensive care unit. 7 Outcomes measured included length of time on 
mechanical ventilation, length of stay in the intensive care unit and cost. 
The study found decreased length of stay in the ICU and length of time 
on the ventilator with the collaborative weaning group. There were no 
significant changes in cost observed. 
Another study found improvements in quality and reduction in cost 
of neonatal intensive care after an interdisciplinary collaboration inter-
vention. Teams from NICUs received instruction in quality improve-
ment, reviewed performance data, identified common improvement 
goals, and implemented ' potentially better practices ' developed through 
analysis of the processes of care, literature review, and site visits. A 
decrease in hospital costs was observed within the year following the 
intervention.8 It is important to note that these studies may be limited 
by the lack of long-term longitudinal studies to examine sustained posi-
tive effects, but suggest there are both system and patient benefits to in-
terprofessional collaboration . In general , collaboration has led to better 
patient outcomes, including reduced morbidity and mortality rates,1 and 
reduced nosocomial infections in ICUs.9 
BARRIERS AND PERSPECTIVES OF COLLABORATION IN 
CRITICAL CARE 
It has been suggested that the attitudes of health care professionals in-
volved in collaborative practice in critical care are pivotal to its success. 
Therefore, negative attitudes can easily be detrimental and adversely af-
fect patient care.1•2 For example, one study found that few health care 
professionals are willing to accept questioning of their decisions, es-
pecially from the nursing staff.10 This leads to nurses further deferring 
to physicians, creating conflict between the desire to be accepted and 
duty to advocate for the patient. 11 The authors of this study suggest that 
this internal conflict, combined with varied degrees of responsibility and 
overlapping competencies can lead to 'role blurring' and confusion of 
one 's expected role within the team.12•13 Unfortunately, the professional 
culture of health care has traditionally promoted hierarchical structures 
with the physician in control , directly conflicting with the cited prereq-
uisite of equal status amongst team members .12•14•15 
While interprofessional collaboration is often welcomed and neces-
sary in the intensive care setting, perspectives differ between each of the 
professions involved. This difference often originates from the identity 
of each profession.12 The professional identity, including cultures, be-
liefs, attitudes, and behaviours, becomes ingrained during the training 
process, and shapes the provider 's own problem solving approaches, 
values, language, and perception of his/her role in a team.12 
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Medicine and nursing are two professions with increasingly overlap-
ping scopes of practice that interact frequent ly during ICU care. How-
ever, the two professions are trained in different manners. Physicians 
are trained to collect information and generate differential diagnoses, 
and to evaluate patient outcomes in the context of the treatment plan.12 
Nurses are traditionally trained to collect data , often simultaneously 
with phys icians, offer observations and impressions, and advocate for 
the patients and families during their time in the ICU. 12 For example, 
when the patient requires a prolonged length of stay in the ICU, the 
physician 's scope of practice is often de-emphasized, and the role of the 
nursing and other health professionals is highlighted e.g., weaning from 
mechanical venti lation, early mobility, fami ly and patient support.16•17 
Due to the differences in professional identities and educational 
training, miscommunications often arise during physician and nurse 
interactions. Nurses may find that when col laborating with physicians, 
physicians are unwilling to accept their input or to make changes. On the 
other band, physicians may perceive nurses as defensive or aggressive 
in telling them what to do fo r the patient. 18 ln some cases, physicians 
may perceive collaboration as having taken place, while their nursing 
colleagues disagree.19 Miscommunication of differing perspectives can 
create treatment plans that fail to address the concerns of each profes-
sion, and negatively affect the patient and fami ly's hospital stay. Ad-
ditionally, collaboration may not be prioritized due to the time needed 
for effective communication and coordination in addition to heavy clini-
cal workloads .20 Despite these challenges, several things can be done to 
overcome barriers and foster a collaborative work environment 
Research studies have shown that three broad elements are neces-
sary for co llaborative practice: clinical expertise, open communication/ 
sharing of knowledge, and a relationship based on trust, empathy and 
respect. 18•21 .23 These elements are essential for uni fying perspectives and 
attitudes, and resolving conflicts during collaboration. It is worth noting 
that the majority of clinical training is geared towards the development 
of clinical expertise and little emphasis is placed on the development of 
"soft skills" including communication, collaboration and conflict resolu-
tion. Many students develop their soft ski ll set through personal experi-
ences and the ' hidden curriculum ' of each profession . Practicing profes-
sionals are able to profoundly influence the collaborative approach of 
students through their own actions and attitudes . 
RECOMMENDATIONS AND CONCLUSIONS 
As medical students, we will be working with many different health care 
professionals during our training. Thus, we wi ll have many opportuni-
ties to develop collaboration skill s, and seek feedback on these skill s 
from both physicians and other members of the team. Unavoidably, we 
will encounter experiences that negatively affect our views of another 
profession , and vice versa. Before letti ng a recent ' negative experience' 
colour our perceptions, we should reflect on the experience through an 
alternate point of view. Through interactions with students and profes-
sionals, we shou ld strive to improve our co ll aborati on skill s to positi ve ly 
impact patient outcome and personal satisfaction. We should also seek to 
gain an understanding of other health care profess iona ls' perspecti ves, 
and to serve as representati ves of our profession. After refl ecting on the 
benefits of having co ll aborated with others, both in personal and pro-
fessional aspects, we are compe ll ed to further advocate for interprofes-
sional co ll aboration. 
Emphasis has been placed on interprofess ional education in the aca-
demic setting as a strategy for physicians to develop co llaboration and 
communication ski ll s.24 However, co ll aborative models enacted in the 
acute care settings continue to be the exception. This is poss ibly due 
to the lack of education and time dedicated to unifying perspectives, 
as well as absence of rewards or incentives to practicing within uch a 
model. ln order to encourage interprofessional cooperation within the 
acute care setting, educational programs that promote opportunities for 
multiple disciplines to work together towards a common goal have been 
recomrnended.25 This may include simulation exercise, or other team 
activities as part of education and training that highlight collaboration as 
a forma lly evaluated objective. Unfortunately, the majority of training 
continues to be provided in isolation, supporting the idea of independent 
roles and responsibilities within the health care system. 
Lastly, we must be aware of our responsibility to foster teamwork 
in our learning environments. We need to be active in seeking feedback 
from preceptors and coworkers regarding our abilities to effectively 
communicate and collaborate as we continue our educational journey. 
By placing more attention on the perceptions and attitudes of profes-
sionals and creating environments that encourage professional under-
standing, we can begin to cultivate co ll aboration in the intensive care 
unit, and beyond. This will allow health care professionals, patients and 
families to profit from the established benefits of collaborative practice. 
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• Services Alberta Physician Opportunities 
Ponoka, Alberta (situated between Edmonton and Red Deer) 
Generalist Physician interested in rehabil itation medicine needed to fill an imminent vacancy at the Halvar Jonson Centre for Bra in injury. 
• Non progressive acquired brain injury long term rehabilitation 
• Multi disciplinary rehabil itation team (OT, PT, SLP, RT, Psychology) 
• Relocation allowance 
• Signing bonus 
• Short term on-site housing may be available 
• The program will provide office space, computer, transcription service and supplies ~ 
Please Contact: 
Dr. Doug Urness 403-783-7643 or Dr. Yolanda Alcaraz-Limcangco 403-783-7810 
Red Deer, Alberta. 
Two Adult Psychiatrists and One Child Psychiatrist needed at the Red Deer Regional Hospital 
Centre (RDRHC). 
• RDRHC serves as the Alberta Health Services Central Zone regional referral centre 
ALBEilTA 
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.. ._.. 
• A modern 373-bed facility which works collaboratively with the Centennial Centre for Mental Health and Brain Injury 
The Adult Psychiatrist positions involve the provision of clinical services to 32 inpatient mental health beds as well as outpatient services in 
a variety of settings. 
Child and Adolescent Psychiatrist support is required for an 8-bed inpatient unit and psychiatric consultation opportunities are available in 
Red Deer and surrounding Community Mental Health Centres. 
Please Contact : 
Dr. Doug Urness 403-783-7643 doug.urness@albertahealthservices.ca or Pamela Kathol403-309-5879 physician@albertahealthservices.ca 
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I magine the plausible scenario of a single motor vehicle collision on a rural highway north of London, Ontario. The 37 year old driver, Willie McKeet, is the sole occupant in the vehicle traveling at ap-
proximately 80 kmlhr. Without warning, a deer jumps out of the bushes 
in front of his car. Panicking, Mr. McKeet werves to avoid the deer, 
loses control of his car and hits a tree bead-on. Another motori st wit-
nesses the coll ision and pulls over to assess the situation. She find the 
man unconscious with laceration on his fo rehead. The front airbags 
have deployed and be bad been wearing his seatbelt. She call s 9-1 - 1. A 
few minutes later, an ambulance arrives on the scene of the colli sion. As 
the paramedics are removing Mr. McKeet from his vehicle they notice 
redness and bruising on his left shoulder and what appears to be the de-
formity of hi s right hip. Willie is loaded into the ambulance and driven 
to the nearest regional hospital--a 20 minutes trip. 
Health care technologies are constantly evolving and their judic ious 
use can improve patient care and hospital efficiency. In this article, we 
will describe several novel technological approaches to managing ur-
gent patient care that may be adapted in the not too di stant future. We 
wi ll fo llow the management of Will ie McKeet from the scene of a ingle 
motor vehicle collision through to the operating room and explore these 
emergent technologies a long the way. 
Use of emerging emergency care technologies will not begin when 
Mr. McKeel reaches the emergency department (ED), but rather in the 
ambulance during transport to the hospital. Traditionally, during trans-
port, very little could be done for this patient. The paramedic would 
assess hi s vitals, control his bleeding, perform li fe- pre erving support 
as necessary and noti fy the hospital of their impending arriva l. The fu-
turistic paramedics who arri ved on the scene of Mr. Mc Keel's accident, 
however, were equipped with an EO-link sy tern . Thi s system consi t 
of two-way audi o, video and data transfer between the paramedic in the 
ambulance and the emergency room staff at the neare t hospita l. 1 The 
portable camera allows the paramedics to end the ED staff rea l-time 
video of the crash scene, all owing them an opportuni ty to better gauge 
the extent and type of injuries that Mr. McKeet may have su tained. 
The li ve two-way voice and video a lso allow Dr. U.L. B. Fine, the ED 
physician who will be treating Willi e, to better ascertain the situation by 
communicating directl y with the paramedi cs. 
During the twenty minute drive to the hospi tal, Dr. Fine and the 
paramedics are in constant communication. The paramedics monitor 
Mr. McKeet's vitals and determine that hi s blood pressure i slightly 
decrea ed, while his heart rate and respiratory rate are slightly e levated. 
They then begin to assess his inj uri es. Willi e has lacerations on his fo re-
head and bruising on his left shoulder that continues diagonally across 
his chest. Dr. Fine determ ines that the patient will need a head CT and 
chest X-ray. A call is placed to the Radiology Department to check the 
ava il ability of the CT scanner and X-ray machines and alert them of the 
patient's imminent arri val. While continuing down the body, the para-
medics note the deformi ty of the right hip as well as inflammation across 
hi s lower abdomen where the lap belt had apparently been sitting too 
high and caused constriction during impact. Dr. Fine, concerned about 
both of these findings, asks the paramedics to use their portable ultra-
sound to take a look at the abdominal cavity and determine the extent 
of any internal bleeding or intestinal devascularisation, common with 
seatbelt injuries.2 Using the Focussed Assessment with Sonography for 
Trauma (FAST) setting on their MobiUS device, a smartphone-based 
ultrasound imaging system,3 the paramedics are able to image both the 
abdomen and hip .2•4 With a c lick of a button, the paramedics send the 
raw video to Dr. Fine who is able to determine that there is free flu id 
around Mr. McKeet 's liver and spleen. The Trauma Team leader is noti-
fi ed and a resident, Dr. Tired, is sent to the ED to assess the patient when 
he arrives at the hospital. Furthermore, Dr. Fine and the radiologist de-
termine that the muscles and ligaments around Mr. McKeet 's hip have 
not been damaged and that pelvic radiograph is not immediately needed 
upon arri val thu , saving time and resources and allowing the staff to 
focus on hi s other inj uries. 
By the time the ambulance arrives at the Emergency Department 
much has already been done. Mr. McKeet has been checked-in elec-
tronically by the paramedics en route to the ED using a hand held com-
puter linked up to the hospita l's computer system. 5 His electronic health 
record have already been retri eved by Nurse Amy, an ED nurse, onto 
a tablet computer givi ng immediate access to a ll his health information. 
She knows that he i a llergic to penicillin, is currently taking metfor-
min to control hi type ll diabetes and has type A negative blood. His 
emergency contact information i readily acce ible and hi fa mily can 
be contacted and in fo rmed of hi s si tuation. Nurse Amy is able to com-
municate thi information to the rest of the team as Mr. McKeet is be-
ing wheeled into the trauma bay. The imaging result collected by the 
paramedi cs are also automatically displayed on hand held tablets for 
fu rther review by the ED staff. The team knows that Willie has abdomi-
nal bleeding and require further imaging once stabilized. They initiate 
the plans they have made to acutely manage his injuries until he can get 
to an operating room. Nur e Amy has prepared several unit of A nega-
ti ve blood fo rtran fusion since Dr. U.L.B. Fine knew Willie would be 
requiring a blood tran fusion based on his condition in the ambulance 
~e l ayed by the .ER-link ystem. Once in the ED, te lemetric technology 
IS used to momtor Mr. McKeet's vita l signs.H These data are automati-
ca lly di splayed on computer screen in the trauma bay and uploaded into 
hi s e lectronic medical records. Once Mr. McKeet ha been stabilized 
he i ent for CT head and C- pine as well as CT thorax abdomen and 
pel vi . :raditi ona lly, tracking down a patient in the hospi~a l is a difficult 
task dunng treatment; ~owever, when Willie' fa mil y arrives panicked 
m the ER, Nurse A~y IS a?le to acti vate the electronic tracking device 
that was placed on h1 s hospita l brace let and inform the fa mily that Willie 
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is currently on his way fro m the radiology suites back to the ED.5 The 
results of Mr. McKeel's CT scans are automatically sent to his electronic 
health record and are viewed by Dr. Tired, the trauma resident, on his 
tablet computer as he awaits Willie's return to the ED. After surgical 
consultation, Mr. McKeet is sent to the operating room for surgery. 
The utility of the novel technologies continues into the operating 
room. Mr. McKeel's imaging results are displayed on large flat screen 
monitors for reference during the surgery. The operating room staff use 
hand held tablets to complete surgical and procedural checklists7 which 
are automatically linked to Willie 's electronic health record . After the 
checklists are complete, Dr. Drugs, an anaesthesiologist, uses hand-held 
computing applications to verify drug information and calculate doses 
for the surgical procedure.8 Once Willie is under anesthesia, the surgery 
begins. The procedure is automatically filmed using a digital camera9 
and a copy is linked to the electronic health record. The video can be re-
viewed by the surgeons for training purposes, quality control measures, 
research purposes or in case of legal action. After surgery, Willie 's lab 
results and further tests are continuously updated in his electronic health 
record. Upon discharge Mr. McKeel's family doctor can review Willie 's 
electronic health record for a detailed chronicle of his hospital stay, al-
lowing for seamless continuity of care. 
These technologies may seem futuri stic; however, several are already 
in use. In a Boston Emergency Department, the SMART system has 
been used to successfully monitor patient vital signs and track patients 
using a gee-positioning system.5 Likewise, telemetric care has been 
successfully applied to various clinical scenarios including the assess-
ment of stroke patients while en route to hospital, 10 remote consultation 
with neurology specialists from large academic centres 11 and 12-lead 
EKG transmission from ambulances to cardiologists. 12 The application 
of telemetric technologies would be especially useful in regions such as 
Southwestern Ontario due to the large number of small rural centres and 
long transit times required to reach Emergency Departments. 
While these technologies are interesting in isolation, their implemen-
tation would be most beneficial in the context of an integrated approach 
through an electronic medical record. These technologies could be eas-
ily implemented in our health care system; however, without a compre-
hensive electronic medical record system their efficacy is not as great. 
We need strong physician leadership and political leadership to imple-
ment these technologies and revolutionize the delivery of emergency 
medical care and improve patient management. 
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An interview with Dr. Shiva Kalidindi 
Joyce Zhang (Meds 2015), Lauren Sham (Meds 2014), Abdul Naeem (Meds 2014) 
She was a 14 year old girl , previously healthy, who suddenly col-lapsed while she was running. When she was brought into the pediatric emergency department, she was waning in and out of 
consciousness. They resuscitated her, got fluids going, but it was still 
unclear why she was fading in and out. Prolonged resuscitations are 
challenging, but this one was particularly so because the etiology of her 
cardiovascular collapse was unclear. This went on for some time. Four 
hours later, while she was being transported to the ICU, she was pro-
nounced dead . In the end, the cause of her myocardial infarction was 
found upon autopsy: an anomalous coronary artery. Usually these pa-
tients would present dead to the ER. But this time, she died in spite of 
their best interventions. 
According to Dr. Shiva Kalidindi, the most challenging part of be-
ing an emergency physician is when the outcome has not gone the way 
that you would like. When he has thought back to this patient, he has 
wondered, "Did I do the right thing at the right time?"Medically, there 
are always questions. But be knows that they did all that they cou ld do 
for this patient. He takes it as a good lesson for him to improve on his 
interaction with the team, as well as an opportunity to do better with 
integrating the family into resuscitation care, keeping them involved and 
constantly updated. This helps them in knowing that everything that can 
be done for their child is being done. 
Dr. Kalidindi is a Pediatric Emergency Physician at Victoria Hospital 
and Associate Director of the International and Elective Program in the 
Global Health Office at the Schulich School of Medicine and Dentistry. 
He attended medical school at Bangalore Medical College in India and 
subsequently completed his Masters in Public Health at the University 
of Albany. He completed his residency and fellowship training in Pedi-
atric Emergency Medicine at the Children 's Hospital of Michigan. He 
then moved to Canada to practice about four years ago. 
Choosing pediatrics was an easy decision, as this was his passion 
during medical school. However, it was not until his rotation in emer-
gency medicine during his residency that he discovered that hi s pro-
fessional niche lied at the interface of pediatrics and emergency medi-
cine. For him, the beauty and fascination of emergency medicine is the 
chall enge of coming up with a diagnosis and then managing or at least 
stabilizing the patient until further care is available. He loves working 
with children in the emergency setting in particular because children 
are relatively resilient to illnesses and they are able to recover quickly. 
"Even the sickest of kids - you walk up to them and say " How are you?" 
and they say "I' m fine! " with a smi le." 
As society becomes more cu lturally diverse, physicians need to be 
experienced in cultural competency. This requires one to keep an open 
mind, trying to understand the fami ly's values and beliefs, while ba lanc-
ing those with our desired clinical approaches and outcomes. It becomes 
particularly important when caring for a child - they usually come with 
parents, if not even more fami ly members. "As long as you can set up 
that common ground: the parents want their child to get better, the child 
wants to go out and play, and physicians want to see their patients get 
better, it becomes easier to take care of them. It 's a joy." Especially in 
pediatrics when it can be impossible to get a history from a child, it can 
really boil down to the parent 's understanding of the child's illness . 
Understanding cu ltural practices is one of the purposes of the Glob-
al Health office. In Dr. Kalidindi 's opinion, global health experiences 
makes one a better physician especially when catering to a diverse popu-
lation . "When you see medicine being practiced in a challenging envi-
ronment, or a resource-restricted environment, it provides you a valu-
able perspective. We do not realize what we have here [in Canada], until 
you see how it is in other places." Most importantly, he wants to make 
international electives a meaningful experience for students. "Having an 
experience is one thing, but being able to reflect on it and learn from it 
is another thing." It is about being an observer as well as a contributor, 
and not a barrier. He says that in order to have a meaningful contribu-
tion, one must have a dialogue with the community - see as to what their 
needs are and how we can potentially address those needs. This can only 
happen iftbere is su tainability to the ongoing collaboration. "What we 
see as beneficial to a local community may not actually be beneficial." 
Being in such a demanding specialty, Dr. Kalidindi advises that the 
key is to achieve work-life balance. For him, it all comes down to the 
abil ity of switching off work when work is done. Emergency medicine 
gives him the luxury of being as diligent as he can be while at work, and 
conver ely the abi li ty to put away his pager when the shift is finished . 
"Even in the most difficu lt of circumstances where I 've had a challeng-
ing patient, which may or may not have gone well , I'm able to go back 
home and spend quality time with my kids and my wife." He succinctly 
states the advantage of working in the emergency department: "Do an 
eight hour shift. Do the best you can. When you're done, you ' re done." 
It is clear that Dr. Kalidindi loves what he does. "The thing with pe-
diatric emergency is that you have a lot of gratifying moments. It 's easy 
gratification. A patient might come in with a radial head subluxation a 
nursemaid 's e lbow. You just walk up to the patient and do a gentle twi~t. 
I mean, the parents think the hand is broken or something and you ' re 
able to fix it! Suddenly the kid is moving their hand and the parents 
think you're a miracle maker - it's beautifu l that way." Despite all the 
challenges, it's clear that pediatric emergency is where he belongs. "We 
are the first to hand out popsicles and stickers in peds emerg. It 's a joy 
to see a child smile! " It definitely sounds like a rewarding place to be. 
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Responding to an emergency- how stress affects 
medical trainees 
Kim Fielding (Meds 2014), Roman Shapiro (Meds 2014) and Elaine Tang (Meds 2015) 
Faculty Reviewer: Dr. Lois Champion, M.D., FRCPC (Department of Anesthesia/ICU) 
Whether arriving as a first responder to the scene of a motor vehicle accident or attempting to resuscitate a patient in the emergency room, medical trainees who find themselves in an 
emergency situation have to think quickly on their feet. The physiologic 
stress response that occurs during such an event is influenced by many 
factors. Most importantly, the individual must assess whether they have 
the resources needed to so lve the problem. These include intellectual , 
social, material and emotional resources. If the individual perceives that 
they have the necessary resources, the situation is defined as a challenge. 
On the other hand, if the individual does not fee l that they are adequately 
equipped to handle the situation, they wi ll experience distress .1 
In any stressful event, the classic "fight-or-flight" response, described 
by Walter Cannon in the 1930s, is achieved by activating the sympa-
thetic nervous system.1 The release of epinephrine and norepinephrine, 
in a matter of seconds, results in characteristic increases in heart rate and 
respiratory rate, as well as diaphoresis and increased blood pressure. In 
addition, the individual may experience fee lings of anxiety. Hans Selye, 
also in the 1930s, divided this response into stages: the alarm phase, in 
which the individual identifies the stressor and activates the sympathetic 
nervous system, the resistance phase, in which the body attempts to cope 
with the stressor, and the exhaustion phase, in which the body is unable 
to continue to function normally.2 
Another dimension of the stress response is the activation of the 
hypothalamic-pituitary-adrenal axis and the subsequent release of cor-
tisol into the bloodstream. This response takes longer to initiate, occur-
ring within 5-40 minutes after the stressor is identified. The result of 
the increased cortisol level is an increase in blood glucose as well as 
variable effects on the brain, specifically in the amygdala, hippocampus 
and prefrontal cortex.1 The amygdala is an area of the brain thought to 
be most closely associated with fear, while the hippocampus has been 
demonstrated as a necessary component in activities relating to memory. 
The prefrontal cortex drives executive functions, such as attention and 
decision-making. 
A large amount of research has been done evaluating the impact of 
stress on an individual 's cognitive abi li ties. Though the results seem 
to be conflicting, there are some common patterns that have been de-
scribed. Studies have shown that an individual 's selective attention to a 
stressor may be enhanced, allowing them to block out other seemingly 
irrelevant information. If the stressor is the situation at hand, as in a 
need to stop bleeding in a car accident victim, then this can be viewed 
as beneficial. On the contrary, if the situation at hand is intubating a 
patient, but the stressor is the attending physician who is judging one 's 
performance, then the attention wi ll be geared toward the physician and 
not the task at hand, which could be detrimental.2 Other researchers have 
shown that tasks requiring divided attention, as in managing multiple 
trauma victims, are impaired due to the stress response.3 One proposed 
mechanism for this impairment is the over activation of protein kinase 
C by norepinephrine in the prefrontal cortex.4 Stress may lead medical 
trainees to experience "tunnel vision" or "premature closure" in which 
they do not consider all possible diagnoses in an emergency situation.2 
Another area of cognition affected by stress is memory. Many experi-
ments have demonstrated that stress impairs working memory, possibly 
due to the dopamine efflux caused by cortisol in the prefrontal cortex.5 
The ability of a medical trainee to remember a variety of information for 
even a short period of time could be drastically impaired if the individ-
ual is in distress. Similarly, memory retrieval is significantly impaired 
during stressful situations, a phenomenon linked with cortisol 's effect 
on beta-2-adrenergic receptors in the hippocampus and the consequent 
decrease in cAMP.6 This impairment is most notable during free recall, 
as compared to recognition memory. There is some benefit of stress on 
memory, nonetheless, and this is in memory consolidation. Stress has 
been shown to improve memory consolidation of events specifically 
linked with the stressor.2 It is important to appreciate, however, that it is 
the stressor and not necessarily the task at hand that wi ll be encoded to 
long-term memory. 
Stress can also impact an individual 's decision-making process, with 
research showing an increase in hyper-vigilant decision-making during 
stressfu l situations.2 This is defined as impulsive, disorganized decision-
making, with increased use of heuristics, which are experience-based 
techniques for problem so lving, learning and discovery. While this may 
be acceptable for an experienced physician with many well-developed 
heuristics, it may not be beneficial to a medical trainee who is just begin-
ning to form such cognitive too ls. One study involving medical radiog-
raphy trainees found a decrease in diagnostic accuracy associated with 
increased anx iety levels.7 
It is appreciated that each individual responds to stressful situations 
a little differently and that unique situations may activate different neu-
ral and hormonal pathways within the same individual. Three important 
factors may influence a medical trainee 's response to stress. The first is 
the individual 's coping style, be it problem-focused, emotion-focused or 
avoidance coping. The second is the individual 's perceived control of 
the situation and whether or not there is thought to be an internal or ex-
ternal locus of control. Finally, the social support of the individual could 
affect the stress response, with increased social support being associated 
with decreased cortisol levels2 
The following scenario is a real example, experienced by one of the 
authors, and illustrates a situation in which a medical trainee may expe-
rience significant stress. 
While doing an observership in a pediatric emergency room, I was 
informed by the doctor that there was a trauma case being brought in 
by ambulance. Suddenly, I f elt much more awake and the entire emer-
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gency room seemed more alive. The paramedics wheeled in a boy on a 
stretcher, unconscious with normal responses to pain, but not much else. 
His mouth and nose were covered with blood, so a nurse passed me a 
gown, gloves and a face mask, explaining, "We don't know what or if he 
has anything. It s always better to be on the cautious side. "As I assisted 
the nurse in removing the boys shoes and clothing and checking for 
I. D. , I observed the doctor and other nurses assess the fundamentals of 
medicine: ABC - airway, breathing, and circulation. 
The patient s periphery was cool to the touch, so they brought in 
warm blankets and covered him from head to toe. His blood pressure 
was taken immediately by one member of the team, while someone else 
checked for his pulse. The doctor cleared the airway, checked the nasal 
passage to ensure there wasn 't a blockage and then assessed for breath-
ing. The head nurse stood to one side, going systematically through all 
the vitals, asking questions as different team members yelled back their 
responses. 
When it was recognized that the ABCs were stable, a visible tension 
left the room as the secondary assessment continued. The patient had to 
be moved from the spinal board to the stretcher and I was called in to 
assist with supporting the patient, while the physician checked for any 
visible or palpable trauma. Next, a urine lox-screen was needed, so I 
was told to hold down the patient while they inserted a catheter. As the 
catheter was being put in, the patient began to fight against the pain and 
four people worked actively to try and hold the patient down. Finally, 
the catheter was in, the urine sample taken, and the catheter removed. It 
was time to fly and wake the patient up. 
In my discussion with the physician after the episode, I learned a 
lot of things. I realized that no one was idle in the procedure room; 
eve1yone worked together as a team to help stabilize the patient. As 
a first year medical student, the experience, while exhilarating, also 
demonstrated to me to the necessity of focus required during emergency 
situations. There isn ~ always time to take a step back and consider all 
your options. Your instincts direct you towards the vitals and as you as-
sess those, you use key markers along the way to indicate the next step. 
Though the physician was tense during the episode, stress did not seem 
to impair the actions of my preceptor. I, on the other hand, felt frozen to 
the spot at times and only moved when instructed to. 
Ultimately, the impact of stress on one's ability to think on their feet 
should not be underestimated. Medical trainees who are in distress will 
experience cognitive changes that affect their attention, memory, deci-
sion-making and more. The positive outlook is that, with experience, 
stress levels should decrease and, in emergency situations, one will be 
better able to think quickly on their feet. 
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A case of an anomalous origin of left main 
coronary artery from right sinus of valsalva leading 
to sudden death 
Yikang Lin (Meds 2014 ), Stephen Cornish (Meds 2015) 
Faculty Reviewer: Dr. Rod Lim MD (Paediatric Emergency Department) 
We spend the bulk of our efforts attempting to understand the basic 
framework of medicine and the top 5- l 0 entries on differential lists. And 
for good reason - these are the things that we will assuredly see and have 
to treat. There are always, however, going to be cases that fall outside 
of the realm of the usual. These cases puzzle the best amongst our pro-
fession and make us wonder if there was anything we could have done 
differently. 
A young adolescent female presented to a pediatric emergency de-
partment with chest pain, shortness of breath, and cyanosis. She had 
been jogging when the chest pain started, and then collapsed. Except 
for a previous possible seizure or syncopal episode a few years earlier, 
she was otherwise healthy. Initial vital signs were a heart rate of 58 bpm, 
blood pressure of70/40 rnmHg, respiratory rate of 50 breaths/min, tem-
perature of37°C, and oxygen saturation of68% on room air. An electro-
cardiogram displayed ST changes suggestive of ischemia.' 
The initial presentation suggests that she was in shock - a patho-
physiologic state of inadequate tissue perfusion and subsequent hypox-
ia.2 It is subcategorized by the underlying mechanisms: reduced blood 
volume ("hypovolemic shock"), a pathological distribution of blood 
volume ("distributive shock"), and/or failure of the pump ("cardiogenic 
pump'').3 If corrected quickly, the short-term effects of poor perfusion 
are generally reversible.2 Prolonged shock, however, will eventually 
lead to irreversible damage including cell death, end-organ damage/fail-
ure, and death .2 
Typically, pediatric patients presenting with shock in the emergency 
department are experiencing hypovolemic shock due to dehydration (re-
sulting from diarrhea or osmotic diuresis) or trauma (and subsequent 
hemorrhage), or distributive shock from sepsis.3 The routine work-up for 
such a patient is to identify and address any life-threatening conditions 
(via a rapid assessment of the patient's general appearance, breathing 
quality and rate, and circulation to skin), recognize circulatory compro-
mise, and then identify the type of shock and find the underlying cause.4 
The detective work involved with this last step includes a detai led his-
tory and physical exam, combined with the necessary anci llary tests.3 
Our patient's history and physical findings suggested a cardiogenic 
cause of shock. One of the more alarming aspects of her presentation 
was her low blood pressure and heart rate. In pediatric populations, a 
low blood pressure indicates a later and more severe stage of shock.2 
Clinically, shock has been described in three progressive stages.3 The 
first stage is compensated shock, in which the body 's homeostatic mech-
anisms (increased heart rate and peripheral vasoconstriction) are able to 
maintain adequate perfusion and systolic blood pressure.2 If left untreat-
ed, compensated shock progresses to hypotensive shoe~, in which the 
compensatory mechanisms are overwhelmed and there ts a subsequent 
drop in systolic blood pressure along with signs of poor perfusion (e.g. 
Left Coronary Artery - Anomalous OriJin 
Figure 1: Standard vs. Anomalous Origin of Coronary vessels (adapted 
from reference II) 
altered mental status).2lfthe inadequate organ perfusion continues, a pa-
tient will eventually progress to irreversible shock, in which end organs 
are irreparably damage, and despite resuscitation , the patient will die.2 
To prevent the progression through these stages of shock, current 
guidelines advise an aggressive, multi-pronged treatment algorithm 
aimed at improving perfusion and end organ function .4 The first arm is 
rapid fluid resuscitation using isotonic crystalloid solution.4 Early vas-
cular access is needed to facilitate fluid resuscitation efforts. Another 
treatment arm is airway and respiratory support in the form of supple-
mental oxygen, positive pressure ventilation, and/or intubation.4 Moni-
toring of physiological indicators (including blood pressure, quality of 
pulses, skin perfusion, mental status, and renal output) before and after 
interventions provide additional clues to the type and underlying causes 
of shock.3 This information would direct the final arm of treatment, the 
selection of appropriate medications.4 
Our patient exhausted the available treatment modalities . She was 
started with peripheral venous lines.' Gravity alone was not enough 
to push the requisite amount of fluid .5 Direct pressure on the bag and 
"push-pull" method were employed to maximize fluid delivery. Addi-
tional vascular lines were established using bilateral intraosseous (IO) 
infusions into her proximal tibias.' These infusions take advantage of 
the veins that drain the medullary sinus of long bones.5 Due to their 
support from the bony-matrix, these veins do not collapse. After can-
nulation to gain access to the medullary sinus using a large bore needle 
and drill, and flushing with normal saline, an IO has equivalent infusion 
rates to a 21 gauge peripheral intravenous catheter. 5 She was placed on 
supplemental oxygen, intubated, and given inotropic medications (do-
pamine at 5-20mcglkg/min, norepinephrine at 0.05-0.5mcglkg/min, and 
epinephrine at 0.1-3.0 meg/kg/min).' Her cardiac output deteriorated, 
and eventually resuscitation attempts were discontinued.' 
The post-mortem examination of the heart revealed an anomalous 
origin of the left main coronary artery (LMCA) from the right sinus of 
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Valsalva.1 The precipitating cau e of death for our patient was deter-
mined to be acute myocardial ischemia. The standard shock manage-
ment regimen was not sufficient to treat her condition, and parts of the 
administered therapy may have been detrimental. 
Under normal circumstances, there are two sinuses ofValsalva aris ing 
from the aorta distal to the aortic valve. Anomalous origin of coronary 
arteries (AOCA) is a rare (estimated 0.1-0.3% prevalence)6 congenital 
heart defect,7 in which coronary vessel(s) follow an abnormal route (see 
Figure 1). Our patient 's left main coronary artery arose from the right 
sinus, passed between the pulmonary trunk and ascending aorta, before 
supplying its dependent heart tissue. Despite its low prevalence, AOCA 
is the second leading cause of sudden death in young athletes, represent-
ing approximately I 0% of deaths in this population6 This discrepancy 
may be due to a high mortality rate associated with thi s condition and/or 
the under diagnosis of this condition (affected individuals are typically 
asymptomatic during daily activities of living). 
AOCA is often included in the differential for sudden cardiac deaths 
in young - albeit as a diagnosis of exclusion. Even so, when the con-
dition actually causes a coronary event due to the insufficient oxygen 
delivery when placed under stre s, it presentation is very difficult to 
discern from other conditions that cause similar symptoms.8 Most cases 
are identified upon autopsy, where myocardial fibrosis in the chroni-
cally under-perfused heart ti ssue and signs of hyper-acute myocardial 
infarction may be evident. In our case, the young gi rl was given inotro-
pic agents in order to increase her cardiac output by increasing force of 
ventricular contraction. 1 However, unbeknownst to the physicians, these 
agents further enlarged her pulmonary trunk and aorta upon each heart-
beat, further occluding her LMCA, and thus exacerbating the ischemia 
of the heart musc le. 
A case like our patient 's wi ll a lways beg the question, what could 
have been done differently? The rea li ty of thi s case is that AOCA is in-
credibly difficult to identify, especially in the emergency setting.9 How-
ever, there is always something that can be gained from evaluating any 
and all aspects of the case in order to gain wisdom and knowledge to 
aid us in future patient care . In this case, there were a few clues. The 
fir t clue was her history. From the literature, the myocardial infarction 
in individuals with AOCA is often preceded by a period of trenuous 
exercise. 7 Our patient was in her teens, otherwise healthy, and had been 
jogging before experiencing non-specific chest pain , followed by col-
lapse and loss of consc iousne s. Exertional syncope is always more con-
cerning than non-exertional. In conjunction wi th her response to treat-
ment, this presentation may have rai ed suspicion of a myriad of cardiac 
conditions, including AOCA. More importantly, on further questi oning, 
the initial presentation had been precipitated by exertion . She had fully 
recovered from that incident, but if she had been sent for further eva lu-
ation it is possible that the defect may have been detected before he 
had a second syncopal episode, and may have been surgica lly corrected. 
Heart function tests includ ing the ECGs and ejection fractions that 
were done for our patient have not been demon !rated to be helpful di -
agnostic tools for coronary artery anomalies.10 Imagi ng, however, all ows 
physicians to note the presence of a congenital defect in the origin of the 
coronary, follow the artery's unusual course, and assess the integrity of 
the artery by looking for region of tenosis. One of the best methods to 
identify this anomaly is the use of computed tomographic angiography 
(CTA) to visuali ze the displaced coronary artery. This type of imagi ng is 
unfortunately not practical in such an emergency setting. Transthoracic 
and transesophagea l echocardi ography have also been demonstrated to 
be feasi ble and practical in young pat ients, and these imaging modali-
ties can be u ed to justify ordering a CTA scan.10 Our patient did get 
an emergent echocardiogram during active resuscitat ion, but the vesse ls 
were not clearly visualized. 1 
Upon identification of the anomaly, treatment is possible t~ough 
surgical means. Coronary artery bypass grafting (CABG) remams ~he 
standard treatment in these instances, with some surgical teams electmg 
to also ' un-roof' the associated anomalous coronary artery.5 This tech-
nique involves modifying the ostium of the coronary artery by excising 
(' un-roofing ') the common wall between the aorta and anomalous artery. 
Attempts to re-implant the anomalous vessel into the correct aortic sinus 
have been completed, but are technically challenging and are not yet in-
dicated over the safer surgical alternatives. Our patient was never stable 
enough to consider this option. 
The medical profession is ripe with challenges for practicing physi-
cians. One of the most mentally difficult tasks required of physicians 
is the need to maintain an expert knowledge of countless medical con-
ditions, many of which are exceedingly uncommon epidemiologically. 
Losing a patient who could have been helped by the correct treatment 
if the proverbial "zebras" had been recognized in time is a true test of a 
physician 's confidence, and is a stark reminder that the science and art 
of medicine demands perfection fro m imperfect people. 
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July 14, 1789. "To arms! " echoed throughout Paris. The city was in a state of unrest and angry mobs roamed the streets. Spurred on by discontent with the monarchy and nobility, Parisians were seek-
ing to gather large quantities of arms and ammunition. This ultimately 
culminated in the storming of the Bastille, an imposing fortress and a 
symbol of monarchical oppression. Its capture galvanized revolutionar-
ies and helped justify their cause. The French Revolution was beginning. 
The French Revolution and the following Napoleonic era trans-
formed the social and political structure of Europe. In three years, 
France's long-standing monarchy was abolished. The aristocracy and 
clergy were stripped of authority as class distinctions were eliminated 
and democracy was established. Ideas of liberty, equality, and citizen-
ship prevailed. The Revolution also marked the beginning of over two 
decades of war that consumed Europe. Revolutionary ideals resonated 
with people beyond France and well after the end of the Napo leonic 
Wars. This period of change and turmoil affected all aspects of human 
life worldwide, and medicine was no exception. 
Indeed, the medical profession contributed to the Revolution and 
was forever changed by it. For Dominique Jean Larrey (1766-1842), 
the storming of the Bastille was a defining moment. On July 14, 1789, 
he led a contingent of 1500 medical students: 
I put myself at the head of these young men .. . and we were the 
first to march against the tyrants . .. Everyone armed himself as 
best as he could and we marched through the night inciting the 
populace to rebellion. On the morning of the fourteenth we armed 
ourselves at the lnvalides and turned our steps towards the Bas-
tille. If we did not have the honour of mounting the first assault, it 
was only because the immense crowd before the gates prevented 
us, and not because we lacked either the enthusiasm or the cour-
age.' 
Larrey would soon become a surgeon in the army of the French revo-
lutionary government and later, surgeon-in-chief to Napoleon Bonapar-
te's Imperial Guard. He strongly believed in the values ofthe Revolution 
and was an idealist. 1•2 While these characteristics created challenges in 
his military career, they fuelled his determination to provide compas-
sionate and humanitarian care for the wounded. Today, he is considered 
the father of emergency medicine. Social revolution and years of war 
created the circumstances necessary for Larrey to implement and de-
velop an unprecedented medical system. 
PRE-REVOLUTION 
Before the French Revolution, medical care was largely absent for 
wounded soldiers . Military operations and manoeuvres had absolute pri-
ority and military commanders believed the wounded simply interfered 
with their battle plans.1•3 Physicians and surgeons seldom belonged in 
armies and responsibility for care fell to fellow soldiers, local inhabit-
ants, and camp-followers. ' Wagons were used to remove the wounded 
after a battle ended, but were required to wait four ki lometres behind 
the army and never arrived in less than twenty-four to thirty-six hourS.4'5 
Regulations denied immediate treatment and evacuation, 1 and soldiers 
often died waiting. Compounding the problem was the status of medical 
officers employed to oversee collection of the wounded. The officers 
were often surgeons, poorly paid, and did not have military rank or au-
thority.1 ·2·6 Surgeons overall belonged to the barber class, were seen as 
inferior to physicians, and lacked social and political power. 7 
REVOLUTION 
The French Revolution had important social implications for surgeons. 
Traditionally trained through apprenticeships and removed from posi-
tions of privilege, they opposed the monarchy and its institutions. Revo-
lutionary France saw a reorganization of universities and medical edu-
cation, with surgeons at the forefront, emphasizing practical learning. 7 
Nonetheless, their newfound prominence in education and civilian life 
was not readily applied to the battlefield. For military medicine, it was a 
case of plus ya change, plus c 'est Ia rnerne chose. 1 
Meanwhile, warfare at the beginning of the Revolution was becom-
ing increasingly violent. Casualties were produced on a large scale as a 
result of military conscription, massive troop formations , and the use of 
concentrated artillery and accurate musketry.8•9 Furthermore, the rise of 
Napoleon ushered in a disregard for military conventions dictating the 
conclusion of battles and procedures for surrender. Instead, armies were 
to be annihilated. The conditions of war created a greater need for medi-
cine to be present, but without a change in the culture of military medi-
cine, the wounded would continue to be overlooked. Military medicine 
required an individual to take initiative and challenge military authority. 
Dominique Jean Larrey was moved by the unnecessary deaths he 
witnessed on the battlefield in 17921·5 and resolved to change the mili-
tary mindset. He once reflected that " the misfortune of others affect me 
strongly. Serious disasters affl ict my soul and plunge me into the deep-
est grief; I often think I can do something to help, and even attempt to 
remedy the situation."2 Fortunately, his conviction, driven by Revolu-
tionary ideals, was aided by the Revolution itself. The Reign of Terror 
was underway and stipulated that anyone caught opposing the Revolu-
tion would be sentenced to death . It enforced Revolutionary values, of 
which equality for all citizens was paramount. Military generals were 
compelled to accept Larrey's proposals and give him permission and 
authority to implement his ideas.' 
INNOVATION 
Larrey wanted to deliver prompt treatment and evacuation to casualties 
on the battlefield. He recognized that delaying treatment complicated 
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patient cases, and lead to hemorrhage, increased pain, infection, and 
death.8 In particular, he went against the predominant practice of waiting 
as long as twenty days to amputate and advocated for surgery within the 
first few hours after injury.2•3•10 lnspired by the quickness and mobility of 
flying artillery, cannons attached to horse-drawn carriages, Larrey cre-
ated the ambulances volantes, or flying ambulances. 
The concept of flying ambulances was first tested in 1793 10 and ap-
proved in 1794.5 There would be two types. A two-wheel model could 
carry two soldiers and was suited for use on flat terrain, while a four-
wheel model could carry four lying casualties and travel across moun-
tains. 4•5 In addition to providing transport, they were equipped for on-
the-spot surgery and medical treatment.' ' The flying ambulances became 
the core of Larrey 's system of medical care. 
Each ambulance unit consisted of a surgeon-in-chief and three divi-
sions of 113 people and 12 flying ambulances.4•10 Larrey was careful 
to include military officers and soldiers in his ambulance teams, since 
medical officers alone did not have any authority on the battlefield. 1 
Whether the situation demanded immediate treatment or evacuation, the 
ambulances would eventually converge at dressing stations or hospitals 
set up at the rear. 
Unfortunately, due to political opposition to Larrey 's plans, his sys-
tem did not debut until 1797 in the presence of Napoleon Bonaparte. 
Napoleon was impressed and praised Larrey: "Your work is one of the 
greatest conceptions of our age. It alone will suffice to ensure your repu-
tation."' The future French emperor 's admiration and support of Lar-
rey 's work helped the flying ambulance system achieve success. The 
presence of flying ambulances in the military boosted the morale and 
confidence of French soldiers. 10 Unsurprisingly, they adored Larrey and 
called him "The Saviour."4•10 
The implementation of flying ambulances was accompanied with 
the conception and development of systems of triage. The multitude of 
casualties, the range of injury severities, and limited resources created 
a necessity for the sorting ofpatients.5 First and foremost , Larrey explic-
itly instructed his medical officers to "always start with the most danger-
ously injured, without regard to rank or distinction ."' This applied to 
both treatment and evacuation. Larrey was also known for providing 
the same quality of care to enemy wounded .3.6·' 2 On resource manage-
ment and military rank, Larrey noted, "The slightly wounded can go to 
the hospital in the first and second line, especially officers because the 
officers have horses."10 With triage, Larrey created a complete, efficient, 
and organized medical system for those wounded in battle when there 
was none to begin with . 
EMERGENCY MEDICINE 
Larrey's unprecedented medical system was established through his de-
termination, and through the circumstances created by the French Revo-
lution and its subsequent wars . His flying ambulances are precur ors 
to the modem ambulance. The basic concepts of triage have remained 
unchanged 13 and are integral to modem emergency rooms, disaster man-
agement, and military medicine. Hi s system reflected the fundamental 
principles of emergency medicine by providing immediate response, 
transport to care stations, care en route, and medical and surgical treat-
ment. Dominique Jean Larrey introduced emergency medicine to the 
world and, with it, revolutionized the way warfare was perceived. The 
wounded were no longer ignored and humanity prevai led despite the 
inhumanities of war. 
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